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PRISM SCORE - PEDIATRIC RISK OF MORTALITY SCORE  
PALS   - PEDIATRIC ADVANNCED LIFE SUPPORT  
ACCM - AMERICAN COLLEGE OF CRITICAL CARE 
 MEDICINE 
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INTRODUCTION 
 Shock is an acute state in which the metabolic demands of the body  
tissues and organs are not met due to inadequate oxygen supply1. It is a major  
cause of morbidity and mortality. In developed countries like US, 37% of  
children in emergency department would be in shock. Of these shock cases, 
majority would be due to sepsis (57%), then hypovolemia (24%), distributive 
(14%) and cardiogenic (5%)2. During shock, body tries to compensate for the 
hypoxic state by attempting to preserve the oxygenation of vital organs like 
brain, heart, liver and kidney at the cost of other organs like muscles, GIT and 
skin. 
DEFINITION 
 Definition at the cellular level is a state of inadequate substrate for 
aerobic cellular respiration as the cardiopulmonary system is unable to supply  
adequate oxygen and glucose for the synthesis of ATP by mitochondria1,11.  
TYPES OF SHOCK3 
1. Hypovolemic : The most common type of shock in paediatrics. 
Common causes includes diarrhoea, vomiting or hemorrhage, 
dengue shock, polyuria like in DKA and sepsis. It is due to loss 
of intravascular volume. 
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2. Cardiogenic shock: It is due to the failure of the heart to pump 
the blood resulting in global hypoperfusion. Common causes 
include congenital heart disease, cardiomyopathies, arrhythmias 
and toxins. 
3. Obstructive shock: It is due to any mechanical barrier that 
impairs adequate cardiac output. Causes include pericardial 
tamponade, pulmonary embolism, tension pneumothorax. 
4. Distributive shock: It is due to inadequate vasomotor tone, 
increased  capillay leak and loss of fluid into the interstitium. 
Examples include anaphylaxis, sepsis, neurological injury 
(spinal shock). 
5. Septic shock:  It is usually due to a complex interaction between 
distributive, hypovolemic and cardiogenic shock. Systemic 
Inflammatory response syndrome (SIRS) is characterised by 
tachycardia, tachypnoea and hyper/hypothermia or high 
leukocyte count. Sepsis is defined as SIRS in the presence of an 
infection either proven or suspected. Septic shock is defined as 
the circulatory failure occurring in the setting of sepsis 
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STAGES OF SHOCK4 
Early compensated shock: 
            In the early stages of shock, due to the compensatory mechanisms, 
there  is release of catecholamines which causes the increase in heart rate and 
systemic vascular resistance (SVR). As a result, children will be able to 
maintain the vessel tone and blood pressure in low flow states of septic and 
cardiogenic shocks. 
 But if left untreated, they will progress on to the decompensated stage.  
Children depend upon tachycardia to increase the cardiac output unlike adults 
where cardiac contractility increases due to the release of catecholamines. 
This is due to the fact that children lack both muscle mass and stiffness in 
their myocardium. 
Decompensated shock: 
             When the compensatory mechanisms fail, the blood pressure will not 
be  maintained. Hence the metabolic demands of the tissues will not be met. 
So the  Tissue hypoxia triggers the anaerobic metabolism resulting in lactic 
acid formation. The vasoactive metabolites namely nitric oxide and adenosine 
gets accumulated locally resulting in leaky capillaries. Derangement of 
hemostasis  occurs leading to microvascular thrombosis. As a result there will 
be multi organ hypoperfusion which leads to clinical shock with hypotension. 
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Irreversible (refractory shock): 
              If the hypoperfusion persists, the child will progress to a state of 
reversible shock where there is complete failure of an organ that will not 
recover despite interventions.  
Pathophysiology of shock 5,14,15,16: 
          The compensatory mechanisms of shock occurs in each system like  
cardiovascular system, respiratory system and renal system. With regard to  
cardiovascular system, compensation occurs by increasing the heart rate, 
stroke volume and the tone of smooth muscles. The respiratory system, to  
compensate for the metabolic acidosis, exhales more amount of carbon 
dioxide. The renal system also excretes more amount of hydrogen ions and  
retains bicarbonate ions to normalise the body pH.  
 Hypovolemic shock is characterised by loss of fluid and a reduction in 
the preload. The increase in the heart rate and the systemic vascular resistance 
are the primary compensatory mechanisms in this type of shock. 
 In distributive shock, there is an abnormal vasodilation leading to 
reduced systemic vascular resistance(SVR). Because of the lowered SVR, 
there is distribution of blood away from the vital organs. So there is an 
increase in the cardiac output as a compensation. So there is reduction in both 
preload and afterload. 
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         In cardiogenic shock, contraction of the heart is affected. This leads to 
systolic and diastolic dysfunctioning. 
 In septic shock, there is usually a combination of distributive, 
hypovolemic and cardiogenic shock. Cardiogenic shock is due to the 
depressant effect of sepsis over the myocardium. Distributive shock is due to 
reduction in the systemic vascular resistance. Hypovolemia is due to 
decreased intravascular volume as a result of capillary leak. 
Systemic Inflammatory response syndrome(SIRS): 
 SIRS is an inflammatory response by the host to any trigger which can 
be either infectious or non infectious. This inflammatory cascade  results in 
various other complications like hypovolemia, ARDS, insulin insensitivity, 
cardiac failure, coagulation abnormalities and uncontrolled secondary 
infections. TNF and certain other inflammatory mediators will increase the 
vascular permeability, causing capillary leak and an impaired balance 
between the perfusion and the metabolic demands of the tissues. Interleukin-1 
and TNF stimulates the release of proinflammatory and antinflammatory 
mediators that causes fever and dilation of blood vessels.7 
Proinflammatory mediators:  IL-6, IL-12, IFN-gamma  
Anti-inflammatory mediatos:  IL-10, IL-14 and TGF-beta 
Arachidonic acid metabolite:  responsible for tachypnea, fever, lactic 
acidosis & ventilation-perfusion abnormalities 
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The pathogenesis of shock is explained in the  figure 1. 
                             Poor perfusion 
                            Cellular hypoxia 
                             Lactic acid accumulation 
                             Fall in pH resulting in metabolic acidosis 
                             Dysfunction of cell membrane  
                             Sodium pump failure 
                             Release of intracellular lysosomes 
                             Entry of toxic substances into circulation 
                             Endothelial damage 
                             Cell dysfunction and death 
 
 
Figure 1: Pathogenesis  of shock 
 
  
Vasoconstriction 
Peripheral blood 
pooling  
Efflux of potassium 
Influx of sodium 
and water 
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Table 1: Identification of shock 
Signs of impaired perfusion 
Organ 
system 
↓ Perfusion ↓↓   Perfusion ↓↓↓   Perfusion 
CNS -- Restless, anxious Agitated/confused 
,coma 
RS -- Ventilation Ventilation 
Metabolism -- Compensated 
metabolic acidosis 
Uncompensated 
metabolic acidosis 
GIT -- Motility Ileus 
Renal Reduced 
Urine output 
Reduced Urine output 
(<0.5mL/kg/hr) 
Oliguria/anuria 
Skin Prolonged 
CRT 
Cool peripheries Mottled, cyanotic, 
cold extremities 
CVS   Heart rate Tachycardia Heart rate 
Weak peripheral pulses   Blood pressure, 
central pulses only 
 
Clinical manifestation8: 
Hypovolemic shock:  Tachycardia, weak pulse, sunken eyes, sunken 
fontanelles, oliguria and a prolonged capillary refill time. Stages of 
hypovolemic shock is shown in the table 2 
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Table 2: Stages of hypovolemic shock 
Stages of hypovolemic shock  
Stage 
% blood 
volume loss 
BP Capillary refill 
1 Up to 15 Maintained Normal Normal 
2 15-25 
Systolic maintained, diastolic 
is raised, pulse pressure 
reduced 
Prolonged 
3 25-40 Systolic decreases Prolonged 
4 >40 Systolic significantly reduced Absent 
 
Cardiogenic shock 12,13 : tachyarrhythmias, weak or absent pulse, 
hepatomegaly and a raised JVP 
Distributive shock     :    Respiratory distress, angioedema, stridor, wheezing, 
early hypotension and a weak rapid pulse. 
Septic shock (warm): Tachycardia, bounding pulses, wide pulse pressure, 
warm extremities, hypotension, altered sensorium.17 
Septic shock (cold) : Cold extremities, poor peripheral perfusion, 
tachycardia, altered sensorium and diminished pulses. 
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Obstructive shock    : Tachycardia, hypotension, deviation of mediastinum to 
opposite side in case of pneumothorax, distended JVP, pulsus paradoxus in  
case of tamponade. 
Certain definitions in pediatric sepsis according to third international  
cocnsensus definitions foe for sepsis and septic shock:  
SIRS 12,24: 
Two or more of the following: 
1. Core temperature of more than 38.50C or less than  360C 
2. Tachycardia with a heart rate of > 90/min 
3. Respiratory rate of  > 20 /min or Paco2 < 32 mm/hg 
4. Elevated WBC count of  > 12000 cells/cu.mm or <4000 cells/cu.mm or 
more than 10% immature  bands 
Infection   : Suspected or proven infection or a clinical syndrome associated  
with high probability of  infection. 
Sepsis   :  Life threatening organ dysfunctioning caused by a dysregulated 
host response to infection. 
Septic shock:   It is a subset of sepsis in which underlying  circulatory and 
cellular / metabolic  abnormalities  are profound enough to substantially 
increase morality18. 
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Mortality in septic shock can be predicted to be >40% if there is persisting 
hypotension requiring vasopressors to maintain MAP > 65 mm/Hg and having 
a serum lactate of >2 mmol/l (18 mg/dl) despite volume resuscitation.9 
Risk of  prolonged ICU stay can be promptly identified at the bed side with 
the use of qSOFA score which is explained below. 
Organ dysfunctioning can be identified as an acute change in total SOFA 
score of > 2 points consequent to the infection. 
Sequential Organ Failure Assessment Score (SOFA) : It includes the 
following parameters : 
· PaO2/FiO2 (mmHg) 
· Platelet count (× 103 / µl) 
· Bilirubin (mg/dl) 
· MAP and inotrope  requirement with regard to CVS 
· Glasgow Coma scale 
· Serum creatinine (mg/dl) and Urine output with regard to renal system 
Quick SOFA (qSOFA)24 : It includes the parameters like respiratory rate of  
> 22 / min, altered mentation and systolic blood pressure  < 100 mm Hg 
Severe sepsis:  Sepsis plus one of the following: 
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1. Cardiovascular dysfunction in the form of hypotension < 5th percentile 
or  SBP < 2SD or a need for inotrope despite >40 ml/kg isotonic IV 
fluid  
OR 
Two of the following: 
 Metabolic acidosis with a base deficit of  > 5 meq/L 
Increased level of lactate (> 2 times the upper limit)  
urine output of < 0.5 ml/kg/hr 
 CRT > 5 sec 
 Core to peripheral temperature gap of > 30C gap 
ARDS (Acute Respiratory Distress Syndrome) as per Berlin is defined as 
the acute onset (within one week of the clinical insult), bilateral opacities on 
chest X ray and respiratory failure not fully explained  by heart failure or fluid 
overload. 
Based on PaO2 /FiO2 of <300mm hg, severity of  ARDS is classified as 
follows: 
Mild         :   300 > Pao2 / FiO2 > 200 with  PEEP > 5 cm of H2O 
Moderate:    200 > PaO2 / FiO2 > 100 with PEEP of  > 5 cm of H2O 
Severe      :    100 > PaO2 / Fio2 with PEEP > 5 cm H2O 
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MODS (Multi Organ Dyesfunction Syndrome)  :  Presence of an altered 
organ function such that homeostasis cannot be maintained without medical 
intervention.10 
Diagnosis of shock: 
 It is mainly a clinical diagnosis which is based on a thorough history 
and clinical examination 19,22. 
Lab findings: 
 CBC- Thrombocytopenia, anemia, elevated  neutrophils 
 PS -   elevated immature forms like bands, myelocytes, vacuolation of 
neutrophils, toxic granulations, dhole bodies 
      Hyperglycemia as a stress response 
      Hypocalcemia 
      Hypoalbuminemia 
      Metabolic acidosis 
      Patients with ARDS – reduced PaO2 & increased PaCO2 
      Fall in SVo2 measured by cooximetry 
      Elevated blood lactate levels (poor tissue oxygen delivery) 
Treatment: 
Initial step: Stabilisation of Airway, Breathing and Circulation Depending 
upon the severity of the shock, intubation can also be planned. 
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 Rapid iv administration of 20ml/kg isotonic fluid; bolus can be 
repeated upto 60 to 80 ml/kg; sometimes fluid resuscitation can go upto 
200ml/kg 23,25. 
 If refractory to initial fluid bolus, then vasopressor therapy is to be 
planned 
Vasopressors used in PICU 
1. Dopamine   :  causes increase in the contractility of the heart and a 
significant increase in the peripheral vasoconstriction at a dose of > 10 
µg/kg/min.  
 Dose is 3 - 20 µg/kg/min20 
2. Dobutamine:  Causes increase increase in the contractility and also is 
a peripheral vasodialator.  
 Dose is 1 - 10 µg/kg/min 
3. Epinephrine:  Causes an increase in the heart rate and an increase in 
the contractility and is also a potent vasoconstrictor. 
 Dose is 0.05 - 3 µg/kg/min 
4. Norepinephrine: It is a potent vasoconstrictor but effect on cardiac 
contractility. 
 Dose is 0.05 - 1.5 µg/kg/min 
5. Phenylephrine: It is a potent vasoconstrictor 
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 Dose is 0.5 - 2 µg/kg/min 
6. Corticosteroids: Hydrocortisone should be reserved for use in 
children with fluid and catecholamine resistance and in adrenal 
insufficiency. Patients at risk include those with severe septic shock, 
purpura and those who received steroids for chronic illness. 
Hydrocortisone is given at a dose of 2 mg/kg iv 
Additional early considerations:  
Septic shock: Early administration of broad spectrum antimicrobial agents is 
associated with reduced mortality. Antimicrobials will have to be planned 
according to the suspected agent. 
Distributive shock: Needs early initiation of vasoconstrictive agents to 
increase SVR though children with this shock benefits from fluid resuscitation 
only temporarily. In case of anaphylaxis, epinephrine would be the agent of 
choice21 
Cardiogenic shock: They have poor cardiac output which is secondary to 
myocardial depression. Only small fluid boluses of 5-10ml/kg is 
recommended. 
Then plan for early initiation of myocardial support with dopamine or  
epinephrine to improve cardiac output; Inspite of adequate cardiac output with 
inotrope, SVR is high and due to poor  peripheral perfusion, an acidosis will 
persist. Hence use of milrinone will be beneficial for these children.  
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Obstructive shock:   Here the mainstay of treatment will be the treatment of 
underlying cause like ICD for pneumothorax, thrombolysis for pulmonary 
embolism, initiation of PGE2 for duct dependent lesions  
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OBJECTIVE OF THE STUDY 
 
·  To study the clinical profile of children getting admitted with shock in 
PICU 
· To analyse the etiology, risk factors, type, severity of shock 
· To analyse the complications and outcome of shock 
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REVIEW OF LITERATURE 
 Shock is a frequent complication seen in pediatric emergency 
departments. Outcome of which depends upon the type and severity of shock 
at the time of presentation. Children with shock needs vigorous management 
in the form of fluid boluses, inotrope support and elective intubation in places 
where necessary. If  left untreated in the early stages, it can progress rapidly 
to decompensated  state and can be fatal. Here are some of the studies done in 
children with shock done in various parts of the country.  
          Kurade A, Dhanawade26 et al, did a study on clinical profile and 
outcome of children with septic shock in PICU in a tertiary care referral 
hospital at Sangli, Maharashtra. The study period was from june 2010 to june 
2013. Children in the age group of  1 month to 18 years were included in this 
study.  94(9%)  out of 1035 children who got admitted had shock of which 
53(56.3%) was septic shock. The male female ratio in the study was 20:23. 
The mean age was 3 years. The common presenting complaint among 
children with shock was fever (62.79%)  followed by altered mental status in 
about 30.23%. Among these children, SIRS criteria was met in about 
35(81.3%). The most common lab parameter that  was found to be abnormal 
was elevated liver enzymes (86.04%) followed  by anemia (62.79%). Next 
common  abnormal parameter was leukocytosis (60.46%). Thrombocytopenia 
(55.81%) and coagulopathy (60.41%) were also seen. The most common 
etiology of sepsis was pneumonia (51.1%) followed by cellulitis/abscess  
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(30.2%). Blood culture was found to be positive in 18.6% in which the most 
common organism was found to be staphylococcus. Among the 
complications, the most common one was MODS (90.69%). Around 74.41% 
of the children presented with decompensated shock and about 97.67% 
required inotropes and majority of  children (88.37%) had required 
mechanical ventilation. The mortality rate in this study was found to be   
60.46% with a mean duration of PICU stay of  8.3 days. They have concluded 
saying that the most common type of shock encountered in PICU was septic 
shock and that carries a high mortality rate. Maximum number of  children 
were under 1 year and the most common underlying etiology was pneumonia. 
          Mariam Santschi et al 27, did a survey on the management of children 
with sepsis and septic shock among the pediatric intensivists of the Reseau 
Mere – Enfant de la Francophonie. The survey was done among the medical 
directors of  20 institutions spread  over four continents. Survey was done 
from November  2010 to March 2011. Survey was conducted by asking the 
physicians to describe the typical management of the patients in their ICU. 
Certain questions will be asked, for eg- regarding investigations, fluid, 
catecholamine management etc... Only thirteen physicians have answered the 
questionnaire of which one was excluded as he was a neonatal intensive care 
unit. Only one PICU reported compliance to all the components of the first 
severe sepsis (sepsis resuscitation bundle). Three PICUs have reported 
compliance to all the elements of second severe sepsis bundle (sepsis 
19 
 
management bundle). In all the centres crystalloids were the fluid of choice 
but none of the centres have used colloids as first line fluid. About 58% of the 
centres considered using catecholamines if the child had not responded for 40-
60ml/kg  of  fluid boluses.  25% of centres have started catecholamines after 
20-40ml/kg of fluids, 8% have started after 60-80ml/kg of fluids and the 
remaining 8% would decide based on the ECHO findings. With regard to the 
choice of Catecholamine, 5 centres (42%) said they would start with 
norepinephrine, 3 (25%) dopamine, 2 (17%) dobutamine and 1 (8%) 
epinephrine. Intubation was considered in about 83% of centres; of which 2 
(17%) would intubate on arrival. The medicines chosen to intubate were: 
atropine in about 36%, short acting neuromuscular blocking agents in 80%, 
ketamine alone in 57%, ketamine with opiates in 29% and 14% with 
etomidate. Only one (8%) have used benzodiazepines. 92% of centres would 
give steroids for refractory shock and 8% would give steroids on arrival. 75% 
of centres would not start insulin  for hyperglycemia (10.5mmol/L blood 
glucose); 17% would start insulin without any protocol and 8% would \ start 
without any written consent. Finally they concluded that the intensivists had 
high adherence to the current recommendations in the management of sepsis 
and septic shock, regarding antibiotics, fluids boluses, inotropes and steroids. 
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           Manjunatha Sarthi et al 28, did a study on adrenal status in children 
with septic shock using low dose stimulation test in a PICU of a tertiary care 
centre in northern India. The study was a cross sectional study to determine 
the prevalence of adrenal insufficiency in children with septic shock using a 
low dose snatched (1microgram) stimulation test. An increment of 
<9microgram/dl after stimulation test was considered as relative adrenal 
insufficiency. The samples for baseline cortical level were taken from 
children with sepsis but without shock for comparison purpose. And then 30 
children (15 girls) with septic shock were included. The median cortical 
values at baseline, 30min and 60 min after stimulation for children without 
shock were 71(48.74-120.23), 78.1(56.9-138.15) and 91(56.17-166.4) 
respectively; whereas for children with shock, the median baseline cortical 
value was 11.5 microgram/dl. 9(30%) of these children had relative adrenal 
insufficiency of which 5(56%) died and among. The remaining 21 children, 
10 died (p=0.69). So they have concluded saying that among the children with 
septic shock, those with relative adrenal insufficiency had a high incidence of 
catecholamine refractory shock (p=0.019) when compared to those with 
normal adrenal reserve but there was no significant difference in mortality 
(p=0.69). 
             Manasaranjan Upadhyay et al 29, did  a  study  to  compare  the  
efficacy between crystalloid (normal saline) and colloid (polymer from 
gelatin in saline-hemaccel) for restoration of intravascular volume in 
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treating children with septic shock. The study design was a prospective, 
randomised, open label trial conducted in the department of paediatrics at 
PGI, Chandigarh. They have included 60 children between 1 and 12 months 
of age with septic shock but without any clinical evidence of organ failure. 
The outcome of the study was analysed based on the hemodynamic 
stabilisation in terms of heart rate, systolic blood pressure, capillary refill 
time, plasma volume at the end of resuscitation and the incidence of organ 
dysfunction. Finally the study was concluded saying that there was no 
significant difference in the efficacy among both the fluids in terms of 
hemodynamic stability and restoration of plasma volume. Normal saline upto 
110ml/kg and gelatin polymer upto 70ml/kg were required in the 1st hour for 
successful outcome.  
              Indhumathy santhanam et al 30, did a study to know the gap 
between the knowledge and the skills for the implementation of ACCM/PALS 
septic shock guidelines in India. The objective of the study was to determine 
if the physicians are aware and had the skills to implement the American 
College of Critical Care Medicine/ Paediatric Advanced Life Support 
protocols for the management of septic shock. Study was conducted in four 
academic institutions in Chennai, Manipal, Mangalore and Trivandrum. Study 
period was between February and April 2006. Analysis was done based on 
pre and post lecture questions. 11 questions to test their knowledge and 10 
questions to test their skills. Totally 118 delegates have participated. among 
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them 114 (97%) were pediatricians and 4 (3%) were anesthetists. Mean 
number of correct response for the 11 questions before the lecture was 2.1 and 
after the lecture was 4.07 respectively (p=0.001). Though 42% of the 
responders were aware of ACCM guidelines, 88 % of them did not follow the 
protocol in their practice; 86 %( n=101) did not feel comfortable in titrating 
the inotropes; 66 %( n=78) were not comfortable in intubating. 78 %( n=92) 
felt that central venous access was not much important in managing refractory 
shock; same way 67 %( n=78) felt that arterial pressure was not important in 
situations like refractory shock. 76 %( n=90) have never introduced an 
intraarterial catheter. They have concluded the study saying that the protocols 
in ACCM/PALS may be hard and inappropriate to be implemented in the 
current Indian setting. Hence simpler protocols are to be implemented to 
educate the community pediatricians inorder to have a better outcome.  
              Rujipat Samransamruajkit et al 31, studied the outcome of septic 
shock in children after utilizing the surviving sepsis campaign at Thailand. 
They have also studied the prognostic significance of the initial plasma NT-
proBNP. They included children in the age group of 1 month to 15 years with 
severe sepsis or septic shock in the study. The initial blood collected was 
saved for NT-proBNP and procalcitonin levels. Totally 47 children were 
included in the study. It was noted that after starting to utilise the surviving 
sepsis campaign, there was a significant reduction in the mortality from 42% 
to 19% over a three year period. 
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 Also they have concluded saying that a significant difference was 
noted in the initial plasma NT-proBNP values between the survivors and non 
survivors. But no significance was noted for the procalcitonin levels. 
NTproBNP level of more than 11,200pg/ml predicted the PICU mortality 
with a sensitivity and specificity of 85.7% and 90% respectively. 
              Suchitra Ranjit et al 32, did a study in a tertiary care PICU at 
Chennai to show the usefulness of bedside echocardiography to decide upon 
the management of fluid and inotrope refractory shock in children. In the 
study they have included children in whom the septic shock was unresolved 
despite 60ml/kg of fluid boluses in the first hour of management and 
refractory to dopamine / dobutamine at 5-10 micrograms/kg/min. The study 
was conducted from july 2005 to September 2007. Twenty two children (22) 
had satisfied the inclusion criteria. Among them 12 were case of warm septic 
shock and 10 were cold septic shock. The mean age group of these 22 
children was 4.9 years and four children of less than 1 year were also there. 
The most common focus for these children with sepsis was pneumonia both 
community acquired and ventilator associated. Seventeen of these children 
were intubated and mechanically ventilated. Bedside echocardiography was 
done for all these children. The commonest echo finding noted was an 
uncorrected hypovolemia in about 12 children and 10 children had myocardial 
dysfunctioning. The type of echo finding and the intervention done were also 
discussed in the study. Seven of these children who had vasodilatory shock 
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with a normal left ventricular function were then given drugs with 
predominant vasopressor activity namely noradrenaline. Five of the children 
with warm septic shock had LV dysfunctioning, hence inotrope in the form of 
dobutamine or adrenaline were also started in addition to the fluid titration 
and the vasopressors. Five out of six of these children with cold shock were in 
volume deficit state. Among those five children, three of them also had 
myocardial dysfunctioning. Then among four children with vasoconstrictive 
shock, one child had collapsible IVC indicting volume depleted state and two 
children had myocardial depression. Hence they were also treated 
accordingly. The net outcome of the study was that shock was resolved in 
seventeen out of the twenty two children. For those ten children who had 
depressed myocardium, a repeat echo was done after 48 hours. The repeat 
echo showed normalisation of the cardiac functioning. 
              A Munde et al 33, did a study in a PICU at Delhi to see the 
relationship between the lactate clearance and PRISM (Pediatric Risk of 
Mortality) score with the mortality. They have included children in the age 
group of one month to thirteen years and the study was conducted between 
May 2012 and June 2013. Samples were collected from a total of 45 children. 
Serum lactate collected at the time of admission and six hours later was 
estimated using Radiometer Copenhagen ABL 555 blood gas analyser. 
Lactate clearance was then calculated by using the following formula: Initial 
lactate - Current lactate * 100 / Initial lactate. A positive value denotes there is 
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lactate clearance and a negative value indicates an increase in the serum 
lactate. Twelve out of forty five children died. The lactate clearance in those 
children who died was significantly low when compared to those who 
survived. It was a significant difference with a p value of (<0.001). The cut 
off for lactate clearance was taken as 30%. The mortality for those children 
with a lactate clearance of <30% was 90%; whereas it was only 8.5% for 
those who had a lactate clearance of >30%. The use of lactate clearance as a 
marker of mortality in PICU is associated with sensitivity and specificity of 
75% and 97% respectively. In the same study it was also found that a high 
PRISM score (>30) was associated with a high prediction for mortality. 
PRISM score was significantly high (>30) for those who died when compared 
to those who survived with a p value of (<0.001).  
               Jay D. Fisher et al 34, studied the clinical spectrum of paediatric 
patients. Presenting with shock and those who developed shock in the 
emergency department. The study period was for 8 years from September 
1998 to September 2006. Around 147 cases of shock were studied in this 
study. Of all the types of shock, in this study, the commonest cause of shock 
was found to be sepsis, around 57%. Of this a pathogen was identified in 
about 45% cases. The next commonest cause of shock was found to be 
hypovolemia (14%). Distributive shock accounted for about 14% of cases. 
Cardiogenic shock was seen in around 5% of cases. The mean fluid 
requirement in children with septic shock was 58ml/kg; While in other types 
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of shock, the requirement was about 50ml/kg. Apart from the fluids, 
vasopressor requirement was seen in 41%. Intubation and mechanical 
ventilation was required in about 21% of cases. Apart from those who 
presented with shock, the study also analysed the number of children who 
developed shock after the admission in an emergency department. It was 
found that around 14% of children developed shock after admission; causes of 
such shock included administration of antimicrobials and a lumbar puncture. 
The overall mortality of shock was 6%. Whereas among septic shock, the 
mortality was found to be 5%. Another important finding noted in this study 
with regard to clinical finding was that, as the child's age increases, 
hypotension is the prevalent clinical sign of shock35.  
               Rabindran et al 36-38, did a study to report the biochemical markers 
that can be used to predict the morbidity and mortality for children with septic 
shock in Billroth hospital, Chennai. As known already, high lactate levels are 
associated more with increased mortality; also lactate has a better prognostic 
value in septic shock than the tumor necrosis factor (TNF) and interleukin-6. 
The survival in septic shock was noted to be better if lactate has decreased in 
one hour of treatment. Next is the absolute neutrophil count; a count of 
<1500/mm3 is associated with increased incidence of septic shock than those 
with a count of >1500 cells/mm3. Procalcitonin, Brain natriuretic peptide and 
caridac troponin T assay were also found to be sensitive markers of mortality 
in septic shock. IL-8 of <220pg/ml was useful in predicting the survival of 
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septic shock with an accuracy of 95% and a value of >220pg/ml had 75% 
sensitivity for predicting he mortality. Increased CD11b expression on 
neutrophils was associated with increased organ failure in septic shock 39. 
Other markers like elevated D-dimer, high mottling score, tissue oxygen 
saturation and derangements of endothelin mediators like VEGF AND sFLT 
were associated with increased mortality and prolonged hospitalisation. The 
three biochemical markers namely CCL3, HSPA1B and IL-8 had a sensitivity  
of 93% and specificity of 74% in predicting he mortality. TREM-1 
(tranmembrane glycoprotein) of >300pg/ml had a sensitivity of 78% and 
specificity of 97% in predicting the mortality in septic shock. 
 En-Pei Lee et al 40, did a study in a PICU at Taiwan. The study was 
conducted from 2003 to 2016. Children included in the study were in the age 
group of 1 month to 18 years. They have retrospectively analysed 50 children 
with shock. Out of which 37 were septic shock children and 3 were 
cardiogenic shock children. The mean age was higher in the septic shock 
group (12.2+4.5) than the cardiogenic shock (9.1+6.1). The aim of the study 
was to study the hemodynamic parameters associated with mortality in these 
two shocks. The parameters like cardiac output was higher in the septic shock 
group than in the cardiogenic shock. The parameters of cardiac contractility 
like cardiac index was significantly higher in the septic shock group with a p 
value of 0.011; the GEF (ejection fraction) was also high in the septic shock 
group with a p value of 0.001.  
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 The cardiac function index was found to be significantly high in the 
septic shock group with a p value of <0.001. The preload and afterload were 
also significantly higher with a p value of 0.05 in the cardiogenic shock. MAP 
was significantly lower  in the non survivors than in the suvivor group of 
septic shock with a p value of <0.05. They have concluded saying that among 
the non survivors of the cardiogenic shock group, cardiac index was 
significantly lower at the time of admission and after 24 hours of admission 
with a p value of <0.05. And among the non survivors of  septic shock, the 
systemic vascular resistance was significantly lower with a p value of <0.001.    
                Daljit singh et al 41, did a prospective study to analyse the etiology, 
type  and outcome of shock among the children in the age group of 1 month to 
15 years in Dayanand hospital at Punjab from July 2001 to December 2002. 
They included a total of 98 cases with a mean age group of 2.8+3.4 years. Out 
of the 98 cases, 39 were found to be in infancy. The male : female ratio of that 
98 children was 1.6:1. The most common type of shock was hypovolemic 
followed by septic, cardiogenic and distributive. 88.9% of the hypovolemic 
shock cases presented in compensated stage whereas in septic shock only 27% 
of the cases presented in compensated stage. Only 3 cases of septic shock had 
blood culture positive with staphylococcus aureus. Among the cases of 
cardiogenic shock, 53% were congenital heart disease children and 23.5% 
were cardiomyopathy cases. The over all survival was 74%. The survival was 
maximum for hypovolemic shock with a p value of < 0.01; followed by 
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53.3% in septic shock and 43.7% in cardiogenic shock. Out of the 24 children 
who died, 23 presented in the decompensated stage.  Twenty two children 
required ventilatory support in which 70% of children expired. Inotrope 
support was required in 45 children out of which 24 children died. They have 
concluded saying that rather than the age of the patient, it is the stage of shock 
at the time of presentation that determines the outcome. Shock itself is 
common among infants than in any other age groups. The commonest type of 
shock was hypovolemic shock with common etiologies being vomiting, 
diarrhea and it had the best prognosis. While the septic shock presenting in 
decompensated stage had the worst prognosis.   
 A Haque et al, did a study at Pakistan to know the association between 
the Vasoactive Inotrope Score (VIS) and mortality of shock. They have 
included children in the age group of one month to sixteen years and with 
fluid refractory shock. It was a retrospective study. It was done for a period of 
two years from January 2011 to December 2012. A total of 71 children were 
assessed. Vasoactive Inotrope Score (VIS) was calculated for these children 
for first 48 hours. The cut-off value for VIS score was taken as 20 based on 
which the groups were classified. Children with a score of > 20 were 
categorised as High VIS group (Group-H) and those with a score of < 20 were 
categorised as Low VIS group (Group-L). 73% of the children were in the 
Group-L. It was found that the mortality rate for children in Group-L was 
38.9% and for those in Group-H was 100%. The overall mortality and case 
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specific mortality of that PICU were 12% and 59.2% respectively; Of which 
the children with fluid refractory shock was 6.3%. And the mortality rate was 
23 (38.9%) in Group-L and 19 (100%) for Group-H. They have concluded  
that high inotrope score was associated with high mortality when compared to 
the low VIS score group. 
 Arigela et al, did a study in a tertiary care hospital at Andhra Pradhesh 
in the period of December 2014 to June 2016. It was a prospective study. 
Children included in the study were in the age group was one month to twelve 
years and those who had clinical diagnosis of shock after a written consent 
from the parents. Out of 75 children. 69.33% had septic shock, 25.33% had 
hypovolemic shock, 2.66% had distributive shock and 2.66% had cardiogenic 
shock. In that 75 children, 74.66% had survived, 25.33% died. According to 
their study the mortality rate was highest for cardiogenic shock (100%) 
followed by septic shock with a mortality rate of 28.84% and hypovolemic 
shock with 10.52%. So they have concluded saying that the commonest type 
of shock was septic shock. Most common cause of sepsis was pneumonia 
(32.69%) followed by sepsis (25%), dengue fever (19.23%) and CNS 
infections  (17.3%). The commonest cause of hypovolemic shock was acute 
gastroenteritis 42-44. There was a significant difference in the systolic blood 
pressure of infants between the survivors and non survivors with a p value of 
0.014. The GCS and SpO2 were also significantly low among the non 
survivors than the survivors. The need for mechanical ventilation for 
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survivors was 16.07% and for non survivors was 73.68%. Children who 
required mechanical ventilation and inotropes were associated with poor 
prognosis. In this study the low mortality rate for septic shock was due to the 
early recognition of the shock and vigorous management according to the unit 
protocols and regular monitoring. 
 Nathan Ford et al 44, did a study to analyse the mortality after fluid 
bolus in children with septic shock. They included thirteen studies which met 
their inclusion criteria. There was a better mortality outcome at 48 hours for 
children with general septic shock with RR 0.69; 95% CI 0.54 - 0.89 and 
children with malaria with RR 0.64; 95% CI 0.45 - 0.91 when no bolus was 
given when compared to giving any bolus. This result was driven by a high 
quality trial (The FEAST trial). But they couldn't find any evidence to analyse 
the mortality of children with dengue fever or severe malnutrition who were 
treated with and without bolus. With regard to type of fluid bolus the efficacy 
of colloid and crystalloid were the same in all the subgroups of shock. So they 
have concluded saying that fluid boluses were harmful when compared to no 
bolus. Hence, they have emphasised on the need of simple protocols for the 
health care providers to decide upon who will get benefited from bolus and 
who will not.  
 Rousseaux et al, did a study to report the prognostic value of shock 
index in children with septic shock. Shock index (SI) is the ratio of heart rate 
and systolic blood pressure. It is a non-invasive measure of assessing the 
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hemodynamic status of the child which helps in early recognition of severe 
sepsis. The objective of this study was to establish the usefulness of this index 
in prognosticating the septic shock. It was a retrospective study. It was 
performed in the PICU at a university hospital. The parameters needed for the 
study were collected at 0,1,2,4 and 6 hours since admission . The data 
collected were heart rate, systolic blood pressure and lactate concentration. 
Totally 146 children were included in the study who got admitted in the 
period between January 2000 and April 2010 with septic shock. They have 
then divided the patients into two groups based on their outcome namely 
Survivors and Non-Survivors. Shock Index showed a significant difference 
between the two groups at 0,4 and 6 hours after admission with a value of 
0.02, 0.03 and 0.008 respectively. If the shock index was abnormal both at 
admission and at 6 hours, it was predictive of death with a relative risk of 
1.36. They have concluded saying that shock index was clinically relevant and 
were useful for predicting the mortality. Rather than using heart rate and 
systolic blood pressure alone shock index would be better for early 
recognition of severe sepsis and to know the prognosis. 
 Sarah J. Atkinson et al 45, conducted a retrospective analysis to 
determine the association between Corticosteroids and outcome in children 
with septic shock. A total of 496 subjects were included in the study . They 
were divided into two groups namely subjects who received corticosteroids 
during the first seven days of admission and those who did not receive the 
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steroids. According to this study the terms 28-day mortality and complicated 
course are defined as death within 28 days and persistence of two or more 
organ failures at 7 days. First they have shown the association between 
corticosteroids and mortality.  There were 64 deaths and the use of 
corticosteroids was significantly associated. With increased risk of death with 
a value of 0.004. Then the association between corticosteroids and 
complicated course was studied.  It was found that there were 133 children 
who had a complicated course. So with the use of corticosteroids there was a 
significant increase in the risk of complicated course with a p value of  0.012. 
Next analysis of subjects without comorbidities in those who received steroids 
was done. There were a total of 321 subjects among them 79% were given  
hydrocortisone, 15 % with methylprednisolone and 6 % with dexamethasone. 
They have also analysed the association between corticosteroids and outcome 
by using PRISM score. According to the PRISM score they have divided the 
children into low, medium and high risk groups and they have analysed the 
association between mortality and corticosteroid use for each group. It was 
found that there was no association between corticosteroids and mortality 
with any group. Same way there was no association between use of 
corticosteroid and complicated course in any group. Also they have analysed 
children without comorbidities and grouped them into corticosteroid received 
and not received. It was found that children who received corticosteroids were 
found to have a greater requirement of inotropes more severe illness, high 
organ failure and a high mortality when compared to children who did not 
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receive corticosteroids. So they have concluded saying that this risk stratified  
analysis failed to demonstrate any benefit from corticosteroids in septic shock 
children.                                             
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METHODOLOGY 
Setting: 
 This was a prospective observational study conducted in Pediatric 
Intensive Care Unit (PICU) in Chengalpattu Medical College. 
Duration of the study: 
 Study was done for a period of one year from September 2016 to 
August 2017.  
Population and sample size:   
 The study included children in the age group of 1 month to 12 years. 
 The sample size of the  study was 100. 
Inclusion criteria: 
 All children in this age group who were admitted with shock were 
analysed. The diagnosis of shock was made clinically based on the findings 
like tachycardia, weak or absent distal pulses, a gap between the core-
peripheral temperature and capillary refill time. Tachycardia 45-46 was defined 
as Heart rate45-46: 2 months to 2 years  > 160 bpm ; 2 to 8 years >110 bpm ; 
above 8 years > 90 bpm. 
 Weak distal pulses were made by comparing dorsalis pedis and 
femoral pulses. Normal femoral pulse is denoted as +++ and dorsalis pulse as 
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++ . Bounding and weak  dorsalis pulses will be denoted as +++ and + 
respectively. Core-peripheral temperature  gap is demonstrated by placing the 
dorsal aspect of one hand over the abdomen while the dorsal aspect of the 
other hand will be used to compare temperature over lower aspect of the body 
with that of the abdomen. Capillary refill time being prolonged is a sign of 
poor peripheral perfusion. It is demonstrated by lifting the child's soul above 
the level of heart and applying an enough pressure to blanch the skin. Normal 
time taken for refill is less than 2 seconds while in shock it is more than 2 
seconds; in warm septic shock it is seen as flash refill.  Pulse Pressure (PP) 
was classified as Normal , Wide and narrow. normal PP is 30 - 40 mm Hg, 
wide PP is > 40 mm Hg, narrow PP is < 20 mm Hg 
 The parameters like  heart rate,  blood Pressure (sytolic, diastolic and 
pulse P ressure) may vary depending upon the etiology and severity of the 
shock. A total of 100 children were included in the study.  
Exclusion criteria: 
 Neonates with shock, children with shock treated outside and details 
unavailable where excluded in the study. Children were recruited for the study 
after  informed consent from parents or care givers at the time of admission.   
Materials and methods: 
 Detailed history including age, gender, fever, convulsions, 
breathlessness, rashes, vomitting , diarrhea , duration of onset of illsness , pre 
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Hospitalisation and  pre Hospital management were collected. Following this 
children were subjected for a detailed clinical examination. Clinical features 
at the time of admission were  recorded. The parameters included 
temperature, heart rate, respiratory rate, capillary refill time, sensorium and 
blood pressure. The sensorium of  the child  was classified as A (Alert) , V 
(Verbal) , P (Pain Responsive) and U (Unresponsive) as per the PEMC 
guidelines rather than the GCS. Based on the clinical findings and history 
from the mother / guardian, shock was classified as hypovolemic , septic, 
cardiogenic and anaphylactic. Based on the blood pressure, severity of shock 
was classified as compensated [ Normal systolic blood pressure: SBP- 
{(2×age) + 70} ] / decompensated (systolic blood pressure less than the 
expected for that age.  
 Following the clinical examination all children were subjected to the 
investigations as per the unit protocol. The investigation included total counts, 
peripheral smear, urea, creatinine, serum sodium, potassium, SGOT, SGPT, 
CRP, blood culture, chest xray and ECHO. The treatment for all the shock 
children depends upon the etiology and severity at the time of presentation. 
The amount of fluid boluses and need for inotropes were decided based on 
guidelines from PEMC and PALS . The need for ventilation and duration of 
stay in the ICU are also included in the study. All these children were 
followed up until their Outcome for complications like MODS, renal failure, 
ARDS, coagulopathy, DIVC and dyselectrolytemia. Platelet counts and 
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hematocrit were frequently monitored for children with dengue shock 
syndrome. 
 Final diagnosis was arrived in these children based on Clinical and / or 
laboratory features for the common pediatric infection. Outcome was then 
classified as discharged , death  and referred . The study was approved by 
institutional ethical committee. The data were entered in excel spreadsheet 
and analysed using SPSS software Version 21 . Simple calculation like 
proportions, percentages and mean values were derived.   
 Appropriate statistical test like Chi-Square test , T test were used to 
compare the study parameters between the survivors and non-survivors. The 
parameters which had a statistical significance with a p value of < 0.05 were 
further analysed by multivariate analysis.                                
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OBSERVATION AND RESULTS 
 The study included 100 children with shock.. In this study, group 1 
refers to survivors and group 2 refers to non survivors. Since the study 
subjects n=100, this will be mentioned as n=% in the result section in all 
statistical analysis involving the entire study group. Demographics like age 
and gender were analysed using simple statistics like proportions.   
 A schematic representation of the study is shown below : 
 
 
 
 
 
 
 
 
Figure 2: Number of cases in shock 
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Figure 3: Types of shock among survivors 
 
 
Figure 4: Types of shock among non-survivors 
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Figure 5: Duration of ICU stay among survivors and non-survivors 
 
 
 
 
 
 
 
Figure 6: Requirement of inotropes among survivors and non-survivors 
 Out of the 100 children, 59 survived, 30 children died and 11 were 
referred out. Since the details about children who were referred are not 
known, analysis was done among survivors and non survivors excluding those 
11 children. 
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1. Gender distribution : 
Table 3:   Gender distribution 
S.No Parameter Male 
(n=51) 
Female 
(n=49) 
1 Gender 51(50%) 49(48%) 
 
 The  table (3) shows gender distribution. Among the 100 children, no 
of males were 51 (50%) and females were 49 (48 %). The male is to female 
ratio was found to be 1.4 : 1 which is depicted in the following pie  
diagram (7) 
 
 
 
 
 
 
Figure 7: Gender distribution 
 Gender distribution among Survivors and non-survivors is depicted in 
the following  table (4): 
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Table 4: Gender distribution among survivors and non-survivors 
Gender 
Group1 
(n=59)  (n%) 
Group2 
(n=30)  (n%) 
Total 
p 
Value 
Female 28(47.5) 15(50.0) 43 
0.903 Male 31(52.50) 15(50.0) 46 
Total 59 30 89 
 
 Children who survived were categorised as Group1 and those who 
didnot survive as Group 2. 28 (47.5 %) girls and 31(52.50%) boys have 
survived. 15(50%) girls and 15(50%) boys died. 
Age   Distribution: 
 The study comprised of children between 1 month and 12 years of age, 
They were classified as infants, toddlers, pre-school children and school 
children. The following table (5) shows age wise distribution: 
Table 5: Age Distribution 
S.No Age(years) Frequency / Percentage 
1 < 1 year 46% 
2 1 - 3 years 23% 
3 3 - 5 years 6% 
4 > 5 years 25% 
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 Out of the 100 children, 46% were less than 1 year, 23 % were 
between 1 and 3 years, 6% were between 3 and 5 years and 25 %  children 
were above 5 years. 
 The same is depicted in the following picture (8).           
 
Figure 8: Age distribution 
3.   Age and Sex Distribution  
 Male and female children in various age group in this study is shown in 
the following table (6): 
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Table 6: Age and gender distribution 
 
Age Females Males 
(years) (n=49) (n=51) 
< 1 year 24 22 
1-3 years 10 13 
3-5 years 3 3 
>5 years 12 13 
 
  In infancy, females were more affected than males. Among pre-school 
children males and females were equally affected and among toddlers and 
school children males were more affected than females. This is depicted in the 
following  picture  (9): 
 
Figure 9: Age and gender distribution 
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4. Presenting symptoms: 
Table 7: Presenting symptoms 
S.NO Clinical Parameter Present Absent 
1 Fever 62(61.8%) 38(37.4%) 
2 Convulsions 51(50%) 49(48%) 
3 Breathlessness 42(41.2%) 58(56.9%) 
4 Rashes 13(12.2%) 87(85.3%) 
5 Vomiting 59(57.8%) 41(40.2%) 
6 Diarrhoea 23(22.5%) 77(75.5%) 
7 Obvious focus 71(69.6%) 29(28.4%) 
8 Pre hospitaliation 42(41.2%) 58(56.9%) 
                  
 In this study 60 (58.8 %) children had fever, 51(50%) had convulsions, 
42(41.2%) had breathlessness, 13(12.2%) had rashes, 59(57.8 5) had 
vomiting, 23(22.55) had diarrhoea, 71(68.6%) had obvious focus, 42(41.2 5) 
had a history of prehospitalisation. The table () shows the presenting symptom  
among  the 100 children.  The same is depicted in the following figure (10). 
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Figure 10: Presenting symptoms 
 And the same as been compared between Survivors and Non-Survivors 
and is shown in the following tables:  
Table 8: Fever among survivors and non-survivors 
Fever 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Present 34(57.6%) 20(66.7%) 59 
0.644 Absent 25(42.4%) 10(33.3%) 30 
Total 
  
89 
 
 Table (8) shows that among the survivors 34 children were febrile and 
25 were afebrile while among non-survivors 18 were ferbrile and 12 were 
afebrile.  
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Table 9: Convulsions among survivors and non-survivors 
Convulsions 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Present 16(27.1) 13(43.3) 29 
0.282 Absent 43(72.9) 17(56.70) 60 
Total 59 30 89 
 
 Table (9) shows that among the survivors 16 children had convulsions 
while among non survivors 13 had convulsions. 
Table 10: Breathlessness among survivors and non-survivors 
Breathlessness 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Present 21(35.60) 14(46.70) 35 
0.185 Absent 38(64.40) 16(53.30) 54 
Total 59 30 89 
 
 Table (10) shows that among the survivors 21 children had 
breathlessness while among non survivors 14 children had  breathlessness. 
Table 11: Rashes among survivors and non-survivors 
Rashes 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Present 10(16.90) 2(6.70) 12 
0.363 Absent 49(83.10) 28(93.90) 77 
Total 59 30 89 
 
 Table (11) shows that among the survivors 10 children had rashes 
while among non survivors 2 children had rashes.  
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Table 12: Vomiting among survivors and non-survivors 
Vomiting 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Present 35(59.30) 18(60.00) 53 
0.949 Absent 24(40.70) 12(40.00) 36 
Total 59 30 89 
  
 Table (12) among survivors 35 children had vomiting while among 
non survivors 18  children had vomiting. 
Table 13: Diarrhoea among survivors and non-survivors 
Diarrhoea 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Present 17(28.80) 6(20.00) 23 
0.102 Absent 42(71.20) 24(80.00) 66 
Total 59 30 89 
  
 Table (13) shows that among the survivors 17 children had diarrhea 
while among the  non survivors 6 children had diarrhoea. 
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Table 14: Pre-hospitalisation among survivors and non-survivors 
Pre 
Hospitalisation 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Present 31(52.50) 8(26.70) 39 
0.038 Absent 28(47.50) 22(73.70) 50 
Total 59 30 89 
 
 Table (14) shows that among the survivors 31 children had history of 
prehospitalisation while among the non-survivors 8 had history of 
prehospitalisation. All the above parameters have been compared between  
Survivors and Non-Survivors and is depicted in the following picture (11): 
 
Figure 11: Presenting symptoms among survivors and non-survivors 
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5. Duration of onset of illness:  
 
 
 
 
 
 
               
Figure 12: Duration of illness among survivors and non-survivors 
 The median duration of onset of illness was 72 hours with 25th to 75th  
interquartile percentile of 24 hours and 96 hours respectively.  
 The same has been compared between survivors and non-survivor and 
is depicted in the    following picture (12):  
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6.  Pre-Hospital Management:  
Table 15: Pre-hospitalisation management 
S.No Pre-Hospitalisation Management Frequency/Percentage 
1 IV Fluid 26(26.5%) 
2 Antibiotic 8(7.7%) 
3 ASV 4(5.9%) 
4 Prazosin 3(2.9%) 
5 None 59(57.8%) 
 
 Among the 100 children, before hospitalisation IV fluids were given 
for 26 children, IV/Oral antibiotics for 8 children, ASV for 4 children, oral 
prazosin for 3 children and about 59 children have not taken any treatment. 
This is shown in the above table (15) 
7. Clinical Parameters: 
Table 16: Vital signs 
S.No Parameter Mean+Std. Deviation 
1 Heart rate 161.32+35.07 
2 Respiratory rate 45.3+24.81 
3 Temperature  101.10+2.81 
4 Systolic BP 80.92+16.4 
5 Pulse Pressure 35.55+10.38 
 
 All the children in the study group were evaluated with their vital signs 
at admission and the findings are tabulated in the following table (16): 
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8. Physiological status at the time of admission :  
Table 17: Physiological status 
S.No 
Clinical             
Parameter 
A V P U 
1 Sensorium 11(10.8%) 35(34.3%) 24(23.57%) 30(29.4%) 
 
 Among the 100 children, 11 children were alert  (A), 35 children were 
verbal (V), 24 were pain responsive (P) and 30 were unresponsive (U) at the 
time of admission. The same is depicted in the above table (17) 
9. Pulse Pressure: 
Table 18: Pulse pressure 
S.No Parameter Frequency/Percentage 
1 Normal 63 
2 Wide 24 
3 Narrow 13 
         
 The above table (18) shows that pulse pressure was normal in 63 
children, wide in 24 children and narrow in 13 children. 
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10. Severity of shock: 
 The following table (19) shows the no of children with compensated 
and decompensated shock at the time of admission: 
Table 19: Severity of shock 
S. NO Severity of Shock Frequency / Percentage 
1 Compensated 87% 
2 Decompensated 13% 
 
 The same has been depicted in the following picture (13): 
 
Figure 13: Severity of shock 
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11.  Type of Shock: 
Table 20: Type of shock 
S.No Type of Shock Frequency/Percentage 
1 Hypovolemic 21 
2 Cardiogenic 20 
3 Distributive 59 
 
 Among the 100 children, 21 were admitted with Hypovolemic shock, 
59  were admitted with distributive shock and 20  with cardiogenic shock. 
This is shown in the above table (20). 
 The same has been compared between survivors and non-survivors and 
depicted  in the following table (21) and picture (14): 
Table 21: Type of shock among survivors and non-survivors 
Type of Shock 
Survivors 
(n=59) (n%) 
Non-Survivors 
(n=30) (n%) 
Hypovolemic 15(25.4%) 4(13.3%) 
Cardiogenic 11(18.6%) 7(23.3%) 
Distributive 33(55.9%) 19(63.3%) 
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Figure 14: Type of shock among survivors and non-survivors 
12. Severity in each type of shock: 
 The following table (22) shows the no. of children admitted with 
Compensated and decompensate stage in each type of shock: 
Table 22: Severity of shock in each type 
Type of Shock 
Compensated 
(n=87) 
Decompensated 
(n=13) 
Hypovolemic 8 12 
Septic 56 1 
Cardiogenic 20 0 
Anaphylatic 3 0 
 
 The same has been compared between survivors and non-survivors and 
is shown in the following table (23): 
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Table 23: Comparison of  severity of shock among survivors and non-
survivors  
Type of Shock Compensated Decompensated Survivors 
Non-
Survivors 
Hypovolemic 8 12 15 3 
Septic 56 1 30 20 
Cardiogenic 20 0 11 7 
Anaphylatic 3 0 3 0 
 
13. Fluid Bolus: 
Table 24: Requirement of fluid bolus 
S.No Fluid Bolus  ( ml/kg ) Frequency/Percentage 
1 <40 51 
2 40 to 80 48 
3 >80 1 
 
 Among the 100 children,  51 children required < 40 ml/kg, 48 children 
required 40 to 80 ml/kg , 1 child required >80 ml/kg. This is shown in the 
above table (24) 
 The same has been compared among survivors and non-survivors and 
table (25) depicts it: 
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Table 25: Requirement of fluid bolus among survivors & non-survivors 
Fluid Bolus   
(ml/kg) 
Group1 
(n=59) n(%) 
Group2 
(n=30) n (%) 
Total p Value 
<40 30(50.8%) 14(46.7%) 44 
0.535   40 to 80 29(49.2%) 15(50%) 44 
  >80 0 1(3.3%) 1 
Total 59 30 89 
 
14. Requirement of inotrope: 
Table 26 : No. of  inotropes required 
S.No No of inotropes required Frequency/Percentage 
1 One inotrope 44(43.1%) 
2 Two inotropes 18(17.6%) 
3 Three inotropes 8(7.8%) 
4 Not Given 30(29.4%) 
 
 The above table (26) shows that among  the 100 children, 44 children 
required one inotrope, 18 children required two inotropes, 8 children required 
three inotropes and 30 were not given. The same was compared between 
Survivors and Non-Survivors in the following table (27) and picture (15): 
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Table 27 : No. of inotropes among survivors and non-survivors 
No of Inotropes 
Group1 
(n=59) n (%) 
Group2 
(n=30) n (%) 
Total 
p 
Value 
One inotrope 30(50.80) 5(16.70) 35 
0.00 
Two inotropes 1(1.70) 17(56.70) 18 
Three inotropes 0(0.00) 8(26.70) 8 
Not Given 28(47.50) 0(0.00) 28 
Total 59 30 89 
 
 
Figure 15: Requirement of inotropes among survivors and non-survivors 
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14. Steroid Response: 
Table 28: Steroid response 
S.No Steroid Response Frequency/Percentage 
1 Responded - 
2 Not responded 24(23.57%) 
3 Not given 76(74.5%) 
 
 The above table (28) shows that among 100 children, steroid  was  
given for 24 children and the remaining 76 children didnot receive steroid. In 
all those 24 children, shock persisted despite corticosteroid therapy  
15. Requirement of inotrope and ventilation : 
Table 29: Requirement of ventilation and inotropes 
S.No Parameter 
Required 
n (%) 
Not  Required 
n (%) 
1 Inotrope 70(68.6%) 30(29.4%) 
2 Ventilation 58(56.9%) 42(41.2%) 
 
 Among all the children included under the study, 70 children have 
required  inotrope and 58 children have required ventilation and the above 
table (29) shows this data. The same has been compared between survivors 
and non-survivors and depicted in the following tables (30) & (31) and 
pictures  (16) & (17): 
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Table 30: Requirement of inotropes among survivors and non-survivors 
Inotrope 
Group1 
(n=59) (n %) 
Group2 
(n=30) (n %) Total p Value 
Required 31(52.50) 30(100.00) 61 
0.00 Not Required 28(47.50) 0(0.00) 28 
Total 59 30 89 
 
 
Figure 16: Requirement of inotropes among survivors and non-survivors 
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Table 31: Requirement of ventilation among survivors and non-survivors 
Ventilation 
Group1 
(n=59) (n%) 
Group2 
(n=59) (n%) 
Total p Value 
Required 19(32.30) 30(100.00) 49 
0 Not Required 40(67.80) 0.00) 40 
Total 59 30 89 
 
 
Figure 17: Requirement of ventilation among survivors and non-
survivors 
16. Lab Parameters: 
                Investigations done for all the 100 children is shown in the 
following Table (32): 
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Table 32 :  Lab parameters 
S.No Parameter Mean + Std. Deviation 
1 CBG 156.68+71.27 
2 Ph 7.10+0.326 
3 HCO3 15.20+4.94 
4 pCO2 31.93+8.8 
5 Na+ 136.99+7.56 
6  K+ 3.73+0.64 
 
 Each of the parameters shown in the above table (32) have been 
compared among the survivors and non survivors and is shown in the 
following tables: 
Table 33 : Mean CBG among survivors and non-survivors 
CBG 
Group N Mean+Std. Deviation p Value 
Group 1 (n=59) 59 156.542+70.6246 
0.675 Group 2 (n=30) 30 163.5+79.3911 
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Table 34: Mean pH among survivors and non-survivors 
pH 
Group N Mean + Std. Deviation p Value 
Group 1 (n=47) 47 7.1211+0.32016 
0.421 
Group 2 (n=26) 26 7.0546+0.36238 
 
Table 35: Mean HCo3 among survivors and non-survivors 
HCO3 
Group N Mean + Std. Deviation p Value 
Group 1 (n=47) 47 15.319+5.1207 
0.529 
Group 2 (n=26) 26 14.538+4.9172 
 
Table 36: Mean pCO2 among survivors and non-survivors 
pCO2 
Group N Mean + Std. Deviation p Value 
Group 1(n=47) 47 31.872+9.2375 
0.693 
Group 2(n=26) 26 31+8.5276 
    
Table 37: Mean sodium among survivors and non-survivors 
Sodium 
Group N Mean + Std. Deviation p Value 
Group 1(n=59) 59 136.339+6.0675 
0.18 
Group 2(n=30) 30 138.633+9.9325 
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Table 38: Mean potassium among survivors and non-survivors 
Potassium 
Group N Mean + Std. Deviation p Value 
Group 1(n=59) 59 3.585+0.4965 
0.008 
Group 2(n=30) 30 4.067+0.8731 
 
17. CRP: 
             The median CRP was 12 mg/dl with  25th and 75th interquartile 
percentile Of  6 and 24 mg/dl respectively. 
18. Total counts: 
 The median total count was 17700 cells/cu.mm with 25th and 75th 
interquartile percentile of 7300 and 23000 cells/cu.mm 
19. Blood culture: 
Table 39: NEC report 
  S.No                    NEC     Frequency/Percentage 
1 Positive 3(2.9%) 
2 Negative 97(95.1%) 
          
 The above table shows that among the 100 children, only three of them 
had growth in the blood culture out of which two where klebsiella and one 
was staphylococcus aureus.   
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20. ECHO:            
Table 40: ECHO findings 
S.No ECHO Frequency/Percentage 
1 LV normal 60(58.8%) 
2 LV dysfunction 9(8.8%) 
3 Pulmonary Hypertension 1(1%) 
4 Not done 30(29.4%) 
 
 Among the 100 children, 60 (58.8%) had a normal LV functioning, 9 
(8.8%)  had LV dysfunctioning, 1 (1%) had pulmonary hypertension and was 
not done  for 30 (29.4%) children. This data is shown in the above table (40). 
21. Duration of shock: 
 The median duration of shock was 3 hours with 25th and 75th 
interquartile percentile of 2 hours and 24 hours respectively. 
22. Duration of stay in ICU: 
 The median duration of stay in ICU is 69 hours with 25th and 75th 
interquartile percentile of 36.5 and 99.5 hours respectively. 
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23. Etiology: 
Table 41 : Etiology of sepsis 
S.No Etiology Frequency/Percentage 
1 Hypovolemia 20 
2 Sepsis 57 
3 Cardiogenic 20 
4 Anaphylactic 3 
 
 The above table (41) shows that among the 100 children, cause for 
shock was found to be sepsis in 57 children, Hypovolemia in 20 children , 
cardiogenic in 20 children and anaphylactic in 3 children. 
 The same was compared among survivors and non-survivors and is 
shown  in the following table (42) and picture (18) : 
Table 42 : Etiology of shock among survivors and non-survivors 
Etiology 
Group1 
(n=59) (n%) 
Group2 
(n=30) (n%) 
Total p Value 
Hypovolemia 15(25.4%) 3(10%) 18 
0.46 
Sepsis 30(50.8%) 20(66.7%) 50 
Cardiogenic 11(18.6%) 7(23.3%) 18 
Anaphylactic 3(5.1%) 0 3 
Total 89 
 
68 
 
 
Figure 18 : Etiology of shock among survivors and non-survivors 
24. Complications: 
Table 43 : Complications 
S.No Complications Frequency/Percentage 
1 MODS 9(6.9%) 
2  Renal failure 7(6.9%) 
3 DIVC 1(1%) 
4 ARDS 1(1%) 
5 Coagulopathy 3(2.9%) 
6 Myocarditis 2(2%) 
7 Hypokalemia 4(3.9%) 
8 None 73(72.5%) 
 
 The above table (43) explains that among the 100 children, 9 children 
developed MODS, 7 had renal failure; ARDS and DIVC were found in one 
child each, 3children had coagulopathy, two had myocarditis and 4 had 
hypokalemia. The same has been depicted in the following picture (19): 
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Figure 19: Complications 
25. Outcome: 
 Outcome of the study group were classified into discharged, referral 
and death  and is shown in the following table (44) 
Table 44: Outcome among 100 children 
S.No Outcome Frequency/Percentage 
1 Discharged 59(57.8%) 
2 Referred 11(10.8%) 
3 Death 30(29.4%) 
 
 Among 100 children who got admitted with shock, 59 have improved 
and got discharged, 30 children died and 11 children were referred out. 
Further details of  11 children who got referred out are not known. Hence they 
were not included in the comparison groups. All the parameters were 
compared between survivors and non-survivors  only. 
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Factors associated with mortality in shock were analysed 
Table 45: Univariate analysis of the parameters for mortality in shock: 
Variables 
Death 
n = 30 
Discharge 
n = 59 
Total 
N=89 
Unadjusted 
OR (95%CI) 
p 
value 
Gender 
Male 
15 
(32.6) 
31 (67.4) 46 1 
0.820 
Female 
15 
(34.9) 
28 (65.1) 43 
1.10 (0.46 – 
2.67) 
Symptom  
Less than two 
symptom 
8 (32.0 ) 17 (68.0) 25 1 
0.831 
> than two 
symptom 
22 
(34.4) 
42 (65.6) 64 
1.11 (0.41 – 
2.98) 
Onset of  Illness* 
< 96 hours 
18 
(25.0) 
54 (75.0) 72 1 
0.001 
> 96 hours 
12 
(70.6) 
5 (29.4) 17 
7.2 (2.23 – 
23.24) 
Prehospital therapy* 
Yes 8 (20.5) 31 (79.5) 39 1 
0.020 
No 
22 
(44.0) 
28 (56.0) 50 
3.04 (1.17 - 
7.93) 
Duration of Shock* 
< 72 hours 
16 
(21.6) 
58 (78.4) 74 1 
0.001 
> 72 hours 
14 
(93.3) 
1 (6.7) 15 
50.75 (6.19 - 
415.6) 
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Fluid Bolus 
< 40 ml / kg 
14 
(31.8) 
30 (68.2) 44 1 
0.709 
> 40 ml / kg 
16 
(35.6) 
29 (64.4) 45 
1.18 (0.49 – 
2.85) 
ICU stay* 
< 96 hours 
12 
(17.6) 
56 (82.4) 68 1 
0.001 
> 96 hours 
18 
(85.7) 
3 (14.3) 21 
28 (7.10 - 
110.4) 
Total Count* 
< 20000 
15 
(26.3) 
42 (73.7) 57 1 
0.049 
> 20000 
15 
(46.9) 
17 (53.1) 32 
2.47 (0.99 - 
6.14) 
Sodium 
Normal (135 - 145) 
22 
(34.4) 
42 (65.6) 64 1  
Low (< 135) 6 (27.3) 16 (72.7) 22 
0.71 (0.24 - 
2.09) 
0.539 
High (> 145) 2 (66.7) 1 (33.3) 3 
3.82 (0.33 - 
44.47) 
0.332 
Potassium 
Normal (3.5 - 4.5) 
21 
(32.8) 
43 (67.2) 64 1  
Low (< 3.5) 2 (11.8) 15 (88.2) 17 
0.27 (0.06 - 
1.31) 
0.043 
High (> 4.5)* 7 (87.5) 1 (12.5) 8 
14.33 (1.65, 
124.2) 
0.002 
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Etiology of shock  
Others 
10 
(25.7) 
29 (74.3) 39 1 0.155 
Sepsis 
20 
(40.0) 
30 (60.0) 50 
1.93 (0.77 - 
4.83) 
 
Number of Inotropes required*  
one 4 (11.4) 31 (88.6) 35 1  
More than one 
26 
(48.1) 
28 (51.9) 54 
7.19 (2.23 - 
23.19) 
0.001 
      
Values in parenthesis are percentage,  *p value <0.05 
Table 46: Multivariate Analysis 
Variables 
Total 
N=89 
Death 
n = 30 
Discharge 
n = 59 
Unadjusted 
OR (95%CI) 
Adjusted OR 
(95% CI) 
p 
value 
Onset of Duration of Illness  
< 96 hours 72 
18 
(25.0) 
54 (75.0) 1 1  
> 96 hours 17 
12 
(70.6) 
5 (29.4) 
7.2 (2.23 – 
23.24) 
0.47 (0.68 – 
3.23) 
0.441 
Prehospital therapy   
Yes 39 
8 
(20.5) 
31 (79.5) 1 1  
No 50 
22 
(44.0) 
28 (56.0) 
3.04 (1.17 - 
7.93) 
2.00 (0.44 – 
9.05) 
0.367 
Duration of Shock  
< 72 hours 74 
16 
(21.6) 
58 (78.4) 1 1  
> 72 hours 15 
14 
(93.3) 
1 (6.7) 
50.75 (6.19 - 
415.6) 
20.47 (0.54 – 
773.05) 
0.103 
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ICU stay*  
< 96 hours 68 
12 
(17.6) 
56 (82.4) 1 1  
> 96 hours 21 
18 
(85.7) 
3 (14.3) 
28 (7.10 - 
110.4) 
8.46 (1.22 – 
58.59) 
0.030 
Potassium  
Normal (3.5 - 
4.5) 
64 
21 
(32.8) 
43 (67.2) 1 1  
Low (< 3.5) 17 
2 
(11.8) 
15 (88.2) 
0.27 (0.06 - 
1.31) 
0.58 (0.04 – 
0.839) 
0.370 
High (> 4.5) 8 
7 
(87.5) 
1 (12.5) 
14.33 (1.65, 
124.2) 
5.90 (0.29 – 
118.66) 
0.246 
Number of Inotropes required*  
Less than 1 35 
4 
(11.4) 
31 (88.6) 1 1  
More than 1 54 
26 
(48.1) 
28 (51.9) 
7.19 (2.23 - 
23.19) 
4.56 (1.10 – 
20.82) 
0.049 
Values in parenthesis are percentage, *p value <0.05 
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DISCUSSION 
 Shock is one of the most common emergencies in paediatrics.  In this 
study, the etiology, clinical profile and outcome of shock is discussed. The 
median age group was 24 months with 25th and 75th  interquartile percentile 
being 5 and 69 months respectively. Majority of children, around 75% were in 
the age group of  >1 month to 5 years. Ravikant M et al and Arigela 
Vasundhara et al also had majority of children in the age group of >1 month 
to 5 years.  In this study, the male : female ratio was found to be 1.4:1. Daljit 
Singh et al stated male : female ratio in their study as 1.6 : 1. However there 
was no effect of  sex over the outcome. Ravikant M et al also concluded the 
same.  
 A total of 100 children with shock were included in the study. Fever is 
the most common presenting symptom (61.8%) in this study followed by 
vomiting (57.8%) and convulsions (50%). Kurade A et al also had fever as the 
commonest presenting symptom. The median duration of onset of illness was 
72 hours with 25th and 75th interquartile percentile being 24 hours and 96 
hours. When the same was compared among survivors and non-survivors, it 
was noted that risk of mortality was more among children who got admitted 
beyond 96 hours of onset of illness when compared to those who got admitted 
within 96 hours. The mean heart rate among the survivors and non survivors 
was 165.254 + 26.49 and 152.367 + 49.96 respectively in this study. Ravikant  
M et al mentioned the mean heart rate among survivors and non survivors as 
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164.87 + 20.71 and 156.59 + 28.87 respectively. In this study, the mean 
respiratory rate was 45.3 + 24.81, mean temperature was 101.10 + 2.81, mean 
systolic blood pressure was 80.92 + 16.4 and the mean pulse pressure was 
35.55 + 10.38. 
                      In this study,  shock due to sepsis was the commonest cause 
(57%), followed by the hypovolemic shock (20%), cardiogenic shock (20%) 
and anaphylactic shock (3%). Mortality was also highest among septic shock 
(66.7%) followed by the cardiogenic shock (23.3%). And the least mortality 
was found in anaphylactic shock followed by hypovolemic shock. Three 
children got admitted with anaphylactic shock and all the three survived. 
Ravikant et al in their study also mentioned that septic shock was the 
commonest (48%) followed by hypovolemic shock (28%) and cardiogenic 
shock (23%).; the highest mortality in their study was noted among septic 
shock children (65.5%) followed by cardiogenic shock (31%) and least 
mortality was found among hypovolemic and anaphylactic. In contrast to 
other studies like Daljit et al have documented that hypovolemic shock is the 
commonest in their study followed by septic, cardiogenic and anaphylactic 
shock and the survival was better in hypovolemic shock. Arigela Vasundhara 
et al had mentioned that out of 75 children with shock, 69.33% were septic 
shock, 25.33% were hypovolemic shock, 2.66% were cardiogenic and 2.66% 
were distributive. Kurade  A et al have identified septic shock to be the 
commonest in their study (56.3%).  Jay D. Fisher et al also concluded that 
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septic shock was the commonest (57%) followed hypovolemic shock (24%), 
distributive shock (14%) and cardiogenic shock (5%).  
 The severity of shock at the time of admission was classified as 
compensated and decompensated. In this study 87 children got admitted with 
compensated shock and 13 children with decompensated shock.  Among the 
children with hypovolemic shock who presented in decompensated state 
84.6% survived and 15.38% have expired. In contrast to a study done  by 
Daljit Singh et al, where number of children with compensated shock was 59 
and those with decompensated shock were 39 in number out of 98 children. 
They have also reported the number of children with compensated and 
decompensated shock in each type of shock namely hypovolemic, septic, 
cardiogenic and distributive. The survival rate of hypovolemic shock  with 
decompensated state in that study is 97.7%. 
           In this study, fluid bolus of <40 ml/kg was required for 51 children, 40 
to 80 ml/kg was required for 48 children among whom 49.2% have survived 
and > 80 ml/kg was required for only one child who did not survive. 
Manasaranjan Upadhyay et al did a study on fluid boluses with crystalloid Vs 
colloid and concluded that normal saline and gelatine polymer solutions were 
equally efficacious; Normal saline upto 110 ml/kg and gelatine upto 70 ml/kg 
were required for successful resuscitation in the first hour. Miriam Santchi et 
al in a study stated that 58% of the centres would prefer use of inotropes after 
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40 to 60 ml/kg of fluids. Nathan Ford et al said that fluid boluses were 
harmful when compared to no bolus 
 In this study, inotrope was required for about 68.6% children and 
ventilator support was required for 56.9% children. According to this study, 
the need for inotropes and ventilatory support were a significant risk factors 
for mortality. Arigela et al concluded in their study saying that need for 
inotropes and mechanical ventilation indicates poor outcome in shock. 
 In this study steroid was given for 24 children and none of them                                  
improved. Sarah J. Atkinson et al in their study concluded saying that their  
risk stratified analysis failed to demonstrate any benefit from corticosteroids 
in paediatric septic shock.  
 In this study, on analysing the requirement of inotropes, need for more 
than one inotrope was a significant risk factor for mortality. 
 With regard to the lab parameters, serum potassium  and total counts  
were significantly elevated among the non survivors group 46. Three children 
have demonstrated growth in blood culture  out of which two were klebsiella  
and one was Staphylococcus aureus. Daljit Singh  et al, who did  a study 
among  98 shock children  also had three positive blood cultures. Kurade A 
Dhanawade et al, also said that the blood culture  yield was very low in their 
study47. This can be explained by  use of  antibiotics  prior to sampling. 
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  In the present study,  prolonged need for ventilation and ICU care was  
significantly associated with mortality.  The mean duration of ICU stay 
among non survivors was 152.50 + 106.20 hours Monteverde et al in their 
study said that prolonged need for mechanical ventilation and ICU stay had 
more complications and mortality was also high for them.   
 Multi Organ Dysfunction Syndrome (MODS) and renal failure were 
the common complications seen in 6.9% and 6.7% children respectively 
followed by coagulopathy (2.9%), ARDS and DIVC seen in 1 case each. Tais  
da Costa Sao Pedro et al said that MODS was seen in 4.3 % cases followed by 
renal failure and abscesses in 3.5 %. They have concluded that the presence of 
complications was a factor associated with death.  
 In this study, 59 children have survived, 30 children expired and 11 
were referred out. The overall mortality was 33.7%48 
 On analysing the risk factors for mortality of children with shock 
certain parameters like prolonged duration of illness (>96 hours), prolonged 
ICU stay (>96 hours),  prolonged duration of shock (>72 hours), high 
potassium levels (>4.5) and requirement of more than one inotrope were 
found to be significant by univariate analysis 49. When these parameters were 
subjected to multivariate analysis,  prolonged ICU stay of > 96 hours and 
requirement of more than one inotrope were found to be significant risk 
factors for   mortality50-53. 
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Limitations in the study : 
           Central venous pressure monitoring (CVP) and  bedside  ECHO would 
have thrown some light towards the monitoring and management of the 
children with shock. 
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SUMMARY 
 In this study, the etiology, clinical profile and outcome of 100 children 
with shock was analysed. The median age group in this study was 24 months 
with 25th   and 75th interquartile percentile of  5 and 69 months respectively. 
Majority of children were in the age group of > 1 month to 5 years. Fever was 
the most common presenting symptom followed by vomiting and 
convulsions. The median duration of  prehospital illness was prolonged 
among the non survivors when compared with the survivors. Septic shock was 
the commonest type of shock followed by hypovolemic, cardiogenic and 
anaphylactic shock. Highest mortality was seen in septic shock followed by 
cardiogenic shock. Out of the 100 children, 87 children presented with 
compensated shock and 13 presented with decompensate shock. Requirement 
of  inotrope was high among non survivors when compared to survivors. 
Requirement of more than one inotrope  and prolonged ICU stay of > 96 
hours were found to be significant risk factors for mortality on multivariate 
analysis. The overall survival and mortality is 66.2% and  33.7% respectively.  
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CONCLUSION 
 
· In the study of 100 children with shock, majority of children were in 
the age group of  > 1 month to 5 years 
· Fever was the most common presenting symptom followed by 
vomiting and convulsions 
· Septic shock was the most commonest type (57%), followed by 
hypovolemic shock (20%), cardiogenic shock (20%) and anaphylactic 
shock (3%). 
· The mortality was highest in septic shock (66.7%)  followed  by 
cardiogenic shock (23.3%) and hypovolemic shock (10%). 
· On univariate analysis, parameters like prolonged duration of illness 
(>96 hours), prolonged ICU stay (>96 hours), high serum potassium, 
requirement of more than one inotrope were found to be significantly 
associated with mortality. 
· Multivariate analysis revealed, requirement of more than one inotrope 
and  ICU stay of > 96 hours to be significantly associated with 
mortality. 
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Recommendation : 
           According to this study, prolonged pre hospital illness and lack of pre 
hospital stabilisation were significantly associated with mortality.  
 Hence in order to reduce mortality,  it is essential to pick up children 
with shock earlier and to refer them with initial stabilisation and a good 
transport care.   
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CHENGALPATTU GOVERNMENT MEDICAL COLLEGE AND 
HOSPITAL DEPARTMENT OF PEDIATRICS 
SI No:         IP NO: 
 
Name: <1 yr 2 – 5 yrs >5 yrs 5-10yrs Age: 
Sex: Region: 
 
HISTORY: 
 
 Yes No Duration 
Fever    
Convulsions    
Breathlessness    
Rashes    
Vomiting    
Diarrhea    
Obvious focus    
 
Duration of illness (hrs) : 
Pre hospitalization (yes or no) :  
 
Heart rate  
Respiratory rate  
Systolic bp  
Diastolic bp  
Pulse pressure  
CBG  
ABG  
94 
 
Cardinal signs yes no 
Temperature   
CRP   
Tachypnoea   
Bradypnoea   
Tachycardia   
Bradycardia   
Wide pulse pressure   
ALOC   
Compensated shock   
Hypotensive shock   
 
 
Duration of shock (hrs)  
Fluid bolus (ml/kg)  
Ionotrope (yes or no)  
Type of ionotrope  
Steroid (yes or no)  
 
 
Investigations Elevated Decreased Normal 
total count    
Hb    
Hematocrit    
MP SMEAR    
urine routine    
urine c/s    
CRP    
NEC    
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Sodium    
Potassium    
 
 
 Increased Decreased Normal 
SGOT    
SGPT    
s.bilirubin    
Urea    
Creatinine    
 
 
Tranfusion yes no 
platelets   
FFP   
PRBC   
 
 
· HOSPITAL STAY: 
 
· DURATION OF FEVER: 
 
· COMPLICATION 
 
· VENTILATORY SUPPORT: 
 
· INOTROPE SUPPORT: 
 
· FINAL OUTCOME: 
 
 
FINAL DIAGNOSIS : 
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PATIENT CONSENT FORM 
STUDY DETAIL: 
“CLINICAL PROFILE ETIOLOGY RISK FACTORS AND 
OUTCOME OF CHILDREN WITH SHOCK IN PICU IN A 
TERTIARY CARE HOSPITAL” 
STUDY CENTER: 
CHENGALPATTU MEDICAL COLLEGE & HOSPITAL, C 
HENGALPATTU 
PATIENT NAME:    PATIENT AGE: 
IDENTIFICATION NUMBER:   FATHER’S NAME: 
 
 I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask the question and all my questions 
and doubts have been answered to my satisfaction. 
 I understand that my child participation in the study is voluntary and 
that I am free to withdraw my child at anytime without giving any reasons, 
without my legal rights being affected. 
 I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in 
respect to the current study and any further research that may be conducted in 
relation to it, even if withdraw from the study, I understand that my child 
identity will not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict the use of 
any data or results that arise from the study. 
 I agree my child to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperative with the study 
team and to immediately inform the study staff if my child suffer from any 
deterioration in my health or wellbeing or any unexpected or unusual 
symptoms. 
 I hereby give consent for my child to participate in this study. 
 I hereby give permission to undergo complete clinical examination 
and diagnostic test on my child . 
 
Signature/Thumb impression: Place: 
Parent name and address:  Date: 
Signature of the investigator: Place: 
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CHILD ASSENT FORM 
 
STUDY DETAIL: 
CLINICAL PROFILE ETIOLOGY RISK FACTORS AND OUTCOME 
OF CHILDREN WITH SHOCK IN PICU IN A TERTIARY CARE 
HOSPITAL  
 
STUDY CENTER: 
CHENGALPATTU MEDICAL COLLEGE & HOSPITAL, 
CHENGALPATTU 
 
PATIENT NAME: PATIENT AGE: 
IDENTIFICATION NUMBER: 
 
 I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask the question and all my questions 
and doubts have been answered to my satisfaction. I understand that my 
participation in the study is voluntary and that I am free to withdraw at 
anytime without giving any reasons, without my legal rights being affected. 
 I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in 
respect to the current study and any further research that may be conducted in 
relation to it, even if withdraw from the study, I understand that my identity 
will not be revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any data or 
results that arise from the study. 
 I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperative with the study 
team and to immediately inform the study staff if I suffer from any 
deterioration in my health or wellbeing or any unexpected or unusual 
symptoms. 
 I hereby give consent to participate in this study. I hereby give 
permission to undergo complete clinical examination and diagnostic test . 
 
Signature/Thumb impression: Place: 
Patient name and address:  Date: 
Signature of the investigator: Place: 
Study investigator’s name:  Date: 
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1 1.00 2 2 2 2 2 1 1 1 48 2 5 180 68 2 2 99.4 3 60
2 1.80 2 2 2 1 2 1 1 1 96 1 2 190 58 2 4 103 2 72
3 11.00 1 1 1 2 2 2 2 1 48 2 5 190 68 2 2 102 1 74
4 8.00 2 1 1 2 2 1 2 2 96 2 2 178 70 2 4 104 1 72
5 8.00 2 1 1 2 2 1 2 2 24 2 5 182 68 2 4 102 1 78
6 72.00 2 2 2 1 2 1 2 1 4 2 5 150 36 2 2 95 1 100
7 1.50 1 1 2 2 2 2 1 1 48 2 5 183 74 2 3 102 1 70
8 11.00 1 1 1 2 2 2 2 1 15 1 1 176 68 2 2 103 1 70
9 72.00 2 2 2 1 2 2 2 1 4 1 3 162 36 2 2 97 1 84
10 132.00 2 2 2 2 2 2 2 1 1 2 4 101 36 2 2 98 1 96
11 36.00 2 1 2 2 2 1 1 1 24 1 1 184 32 2 3 103 3 66
12 48.00 1 1 2 2 2 1 2 2 72 2 5 163 28 2 3 102 1 80
13 12.00 1 1 2 1 2 2 1 1 96 2 5 173 68 2 2 102 1 74
14 120.00 2 1 2 2 2 1 2 2 48 1 1 143 40 2 2 99 1 94
15 1.50 2 1 2 1 2 2 2 1 168 2 5 170 82 2 3 100 3 52
16 24.00 1 1 1 2 2 2 2 1 168 2 5 126 20 1 3 102.4 1 74
17 15.00 2 2 1 1 2 1 1 1 24 1 1 188 64 2 3 103.4 1 70
18 10.00 2 1 2 1 2 1 2 2 192 2 5 190 20 2 4 104.2 1 70
19 11.00 2 1 2 1 2 1 2 2 360 1 1 188 72 1 2 100.1 1 72
20 6.00 1 1 1 1 2 1 2 1 24 1 1 178 28 3 4 103.4 1 74
21 1.20 2 1 2 2 2 1 1 1 24 2 5 182 74 2 3 104 1 70
22 72.00 2 1 2 2 1 1 2 2 96 1 1 140 28 2 2 100.2 3 70
23 96.00 1 1 2 2 1 1 2 2 96 1 1 142 24 2 2 98.4 3 72
24 48.00 2 1 2 2 2 1 2 2 72 1 1 156 28 2 2 98.5 1 80
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25 60.00 1 1 1 2 2 1 2 1 96 2 5 155 48 1 4 101.4 1 84
26 10.00 2 2 1 1 2 2 2 2 24 2 5 168 30 2 4 100 1 72
27 5.00 2 2 2 1 2 1 2 2 48 1 2 202 92 2 4 100.1 1 70
28 96.00 1 1 2 1 2 2 2 2 72 2 5 158 48 1 1 100.2 1 90
29 1.60 1 1 2 1 2 1 1 1 48 1 1 206 72 2 3 104.2 1 70
30 132.00 1 2 2 1 1 2 1 1 1 1 2 153 48 2 3 98 1 100
31 84.00 2 2 2 1 2 1 2 1 4 1 1 132 40 2 2 95 1 100
32 60.00 2 1 2 2 2 1 1 2 100 1 1 170 48 2 4 104 1 84
33 72.00 2 2 2 2 2 2 2 1 168 2 5 68 28 1 1 98.6 1 84
34 10.00 1 2 1 1 2 2 2 1 3 2 5 183 24 2 4 102 1 74
35 12.00 1 2 1 2 2 1 2 1 72 2 5 54 10 2 4 100.3 2 130
36 12.00 2 1 2 2 2 1 1 1 48 1 5 170 72 2 3 98.4 1 74
37 2.00 1 2 1 2 2 2 2 1 24 1 1 46 24 2 4 100.2 2 126
38 1.50 1 2 1 2 2 2 2 2 24 2 5 132 48 1 1 99 1 67
39 84.00 1 1 2 1 1 2 2 1 480 2 5 134 32 1 1 103 1 86
40 11.00 2 1 2 1 2 2 2 1 168 2 5 190 68 1 1 104.2 1 70
41 72.00 2 1 2 2 2 1 2 1 72 2 5 180 48 2 3 105 1 86
42 36.00 1 1 1 2 2 2 2 2 168 2 5 150 44 2 3 104.4 1 80
43 6.00 2 1 2 1 2 1 1 1 48 2 5 208 70 2 4 103.3 1 67
44 24.00 1 2 2 2 2 2 1 2 2160 2 5 168 40 1 2 98 2 120
45 36.00 2 1 1 2 2 1 2 1 6 2 5 40 0 2 4 95 3 60
46 4.00 2 1 2 1 1 2 2 2 72 2 5 187 72 2 2 103.6 1 70
47 144.00 2 1 2 2 1 1 2 2 96 1 5 130 24 2 1 100.2 1 100
48 72.00 1 1 2 2 1 1 2 1 120 2 5 128 28 2 2 100.3 1 100
49 6.00 2 1 2 1 2 2 1 1 48 2 5 211 70 2 4 104.2 3 50
50 120.00 1 2 2 2 1 1 2 1 96 1 1 120 28 1 1 98.6 1 90
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51 36.00 2 1 1 2 2 1 2 1 24 2 5 170 0 2 4 104.2 1 80
52 24.00 2 2 2 2 2 2 1 1 72 2 5 180 52 2 3 99 3 60
53 36.00 2 2 2 2 2 1 2 1 6 1 1 150 44 2 2 95 1 80
54 1.10 1 1 1 1 1 2 2 2 96 2 5 192 74 3 2 103.4 1 70
55 10.00 1 1 1 2 2 1 2 2 108 2 5 180 42 2 4 103 1 80
56 132.00 2 1 2 2 1 1 2 1 96 2 5 120 28 2 1 98 1 96
57 11.00 1 2 1 1 2 2 2 2 3 2 5 163 68 2 4 99 1 76
58 1.70 2 2 1 2 2 1 2 1 72 2 5 53 0 2 4 100 2 130
59 3.00 1 1 1 2 2 1 2 2 96 2 5 183 74 2 2 103.4 1 70
60 72.00 2 1 2 2 2 2 2 1 72 2 5 180 40 2 2 104 1 86
61 120.00 2 1 2 2 2 1 2 1 96 2 5 120 28 1 1 100 1 90
62 36.00 1 2 2 2 2 2 1 1 48 1 5 170 44 2 3 100 3 70
63 30.00 2 2 2 2 2 2 1 1 72 2 5 192 70 2 4 95 3 62
64 36.00 2 1 1 2 2 1 2 1 4 1 1 173 74 2 4 104 1 74
65 3.00 1 1 2 1 2 1 2 1 168 1 2 175 78 2 2 103.4 1 70
66 5.00 1 1 2 1 2 2 2 2 96 1 2 170 84 2 2 98.3 1 84
67 108.00 2 2 2 2 2 1 2 1 4 1 3 130 28 1 2 99.4 1 100
68 84.00 1 2 2 2 2 2 2 1 3 1 3 140 24 1 3 99 1 100
69 96.00 1 1 1 2 2 1 2 2 72 2 5 182 0 2 4 104.4 1 96
70 120.00 1 2 2 1 2 1 2 1 4 1 4 150 48 2 2 95 2 128
71 4.00 2 1 1 2 2 1 2 2 10 2 5 170 0 2 4 103.2 1 74
72 36.00 1 1 2 2 2 1 2 2 168 2 5 174 40 2 2 104.6 1 78
73 3.00 1 2 2 1 2 2 1 1 72 1 1 180 74 2 3 102 1 70
74 1.30 2 1 2 1 2 1 2 1 96 1 2 180 68 2 3 103 1 70
75 2.00 2 1 1 1 2 1 2 2 24 2 5 178 0 2 4 103.4 1 70
76 60.00 1 1 2 1 2 1 2 2 168 2 5 170 40 2 3 102.3 1 80
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77 12.00 2 1 2 1 2 1 2 1 168 1 1 182 64 1 2 103.5 1 70
78 120.00 1 1 2 1 2 2 2 1 144 2 5 162 44 1 2 104.5 1 100
79 10.00 2 2 1 2 2 2 2 1 5 2 5 193 0 2 4 105 1 70
80 108.00 1 1 2 2 1 1 2 2 120 1 1 158 44 2 2 100 3 80
81 1.50 1 2 1 2 2 2 2 1 48 2 5 178 52 1 1 98.6 1 66
82 3.00 1 2 1 2 2 1 2 1 72 2 5 68 0 2 4 100.3 3 128
83 18.00 1 2 1 2 2 2 2 1 3 1 1 170 0 2 4 98.6 1 90
84 24.00 1 1 1 2 2 2 2 1 48 2 5 183 0 2 4 104.5 1 76
85 24.00 1 1 2 2 2 1 1 1 168 2 5 171 32 1 3 102.4 1 74
86 24.00 2 1 2 1 2 2 2 1 168 2 5 178 68 2 2 103.4 1 70
87 1.50 1 2 2 1 2 1 1 1 72 1 1 180 78 2 3 104 1 66
88 24.00 2 2 2 1 2 1 2 1 3 1 4 156 68 2 2 97 1 80
89 36.00 1 1 1 2 2 2 1 1 48 1 1 170 48 2 3 103.4 2 100
90 1.20 2 1 2 1 2 2 2 1 96 1 2 180 76 2 3 104 1 80
91 12.00 1 2 2 2 2 1 1 1 48 1 1 178 56 2 4 96 3 50
92 24.00 1 1 2 1 2 2 2 1 72 2 5 200 52 2 2 104.3 1 90
93 4.00 1 1 2 1 1 1 2 1 168 2 5 204 74 2 2 104.2 1 80
94 2.50 1 2 2 1 2 2 2 1 48 2 5 183 84 2 2 98 1 76
95 60.00 2 1 2 2 1 1 2 1 96 1 1 120 24 2 2 100.3 1 80
96 36.00 2 2 2 1 2 1 2 1 3 1 1 140 32 2 2 96 2 100
97 30.00 2 2 2 1 2 1 2 1 2 2 5 172 68 1 3 100.2 1 80
98 36.00 2 1 1 1 2 2 2 1 48 2 5 170 0 2 4 104.4 1 80
99 72.00 1 2 2 2 2 1 2 1 2 1 3 150 24 1 1 100.2 1 84
100 1.70 1 1 2 2 2 1 1 1 48 1 1 203 74 2 3 104.3 1 80
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1 280 1 2 2 5 3 4 2 33 12 17000 2 135 3.8 1 1 1 4
2 30 42 240 1.5 2 2 5 3 4 1 96 24 24000 2 134 2.2 2 4 1 4
3 30 44 340 2 2 1 1 3 4 2 72 24 22000 1 142 4.2 2 4 1 1
4 40 32 52 2.5 1 1 1 3 4 1 96 24 18000 2 137 3.4 2 4 1 1
5 20 58 270 1.5 2 1 3 3 1 1 288 12 21000 2 166 4.2 2 4 3 3
6 64 36 178 1 1 1 2 3 1 2 40 6 6000 2 133 3.6 3 3 1 1
7 30 40 132 0.6 2 2 5 3 4 2 72 24 19000 2 136 3.7 2 4 1 4
8 40 30 170 2 2 1 1 3 4 2 96 6 8000 2 140 4.2 2 4 1 1
9 50 34 180 2 1 1 2 3 1 2 100 12 10000 2 138 3.9 3 3 1 1
10 60 36 120 3 1 1 2 3 2 2 120 6 9000 2 140 3.8 3 3 1 1
11 30 36 102 5 2 1 1 3 4 2 96 24 4400 2 126 3.5 1 1 1 1
12 40 40 103 48 2 1 3 3 1 1 96 24 8000 2 141 3.9 2 4 3 2
13 30 44 192 1 2 2 5 3 1 2 72 6 13000 2 122 3.1 2 4 1 4
14 40 54 99 1 2 2 5 3 1 2 96 6 4200 2 130 3 2 4 1 4
15 30 22 190 16 1 1 2 3 2 1 24 12 15000 2 126 5.2 3 3 3 2
16 40 34 85 160 1 1 3 2 1 1 264 6 9800 2 121 3.6 2 4 3 3
17 40 30 177 24 2 1 3 3 4 1 96 12 19000 2 138 3.7 2 4 3 2
18 20 50 203 48 2 1 4 3 1 1 312 24 32000 1 141 4.3 2 4 3 3
19 46 26 88 90 1 1 3 2 1 1 168 6 11000 2 143 4.5 2 4 3 2
20 20 54 223 60 2 1 4 3 1 1 72 12 29000 2 121 5.8 2 4 3 2
21 30 40 181 1.5 2 2 5 3 1 2 24 24 30000 2 135 3.1 2 4 1 4
22 50 20 94 1 1 2 5 3 1 2 48 6 3200 2 122 3.9 1 1 1 4
23 54 18 110 1 1 2 5 3 1 2 48 6 2800 2 127 4.6 1 1 1 4
24 64 16 129 1 1 2 5 3 4 2 48 6 4200 2 125 3.4 1 1 1 4
25 40 44 174 96 1 1 3 2 1 1 336 24 23300 1 138 5.2 2 4 3 3
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26 40 32 320 1 1 2 5 3 1 2 24 6 6400 2 137 3.9 3 3 1 4
27 40 30 108 10 1 1 2 3 2 1 12 12 18000 2 138 3.6 3 3 3 1
28 60 30 94 96 2 1 3 2 1 1 288 12 21000 2 140 3.6 2 4 3 2
29 20 50 203 24 2 1 4 3 1 1 36 24 30000 2 138 3.8 2 4 3 2
30 60 40 154 0.5 1 2 5 3 2 2 48 6 9100 2 142 3.4 3 3 1 4
31 60 40 102 2 1 1 2 3 2 2 36 6 9400 2 146 3.5 3 3 1 1
32 30 54 95 72 2 1 4 3 1 1 96 24 23000 2 138 6.1 2 4 3 2
33 50 34 87 72 2 1 3 2 1 1 192 6 7400 2 140 3.5 3 3 3 3
34 40 34 270 2 1 1 1 3 4 1 48 6 8300 2 138 3.6 3 3 1 1
35 84 46 352 96 1 1 3 2 1 1 168 12 19200 2 143 2.3 3 3 3 2
36 30 44 98 1.5 2 2 5 2 4 2 36 12 31000 2 144 3.8 2 4 1 4
37 84 42 102 90 1 1 3 2 1 1 192 6 7800 2 138 4.2 1 1 3 3
38 40 27 108 100 1 1 3 2 4 1 192 12 26000 2 142 4.3 3 3 3 2
39 40 46 92 110 2 1 3 2 1 1 168 24 24000 2 143 4.2 2 4 3 2
40 40 30 96 96 2 1 3 2 4 1 336 24 27000 2 142 4.6 2 4 3 3
41 40 46 106 1.5 2 2 5 3 4 2 72 6 24000 2 141 3.8 2 4 1 4
42 30 50 302 74 2 1 4 3 4 1 144 24 28000 2 133 4.6 2 4 3 2
43 10 57 225 3 2 1 4 3 1 1 48 24 31000 2 145 4.5 2 4 1 1
44 86 34 86 10 1 1 3 2 1 1 360 24 32000 2 168 2.2 2 4 3 2
45 ? 271 24 2 1 3 2 1 1 36 6 18000 2 134 3.5 2 1 3 2
46 20 50 103 90 1 1 4 3 1 1 192 24 3000 2 135 3.8 2 4 3 3
47 80 20 94 2 1 2 5 3 1 2 48 6 3100 2 144 3.6 1 1 1 4
48 80 20 78 2 1 2 5 3 1 2 36 6 4100 2 130 3.7 1 1 1 4
49 ? 274 12 3 1 4 3 4 1 144 24 19000 2 136 3.6 1 1 3 2
50 70 20 98 2 1 2 5 3 1 2 48 6 2600 2 121 3.7 1 1 2 4
51 50 30 183 3 1 1 1 3 1 2 36 12 23000 2 136 4.3 2 4 1 1
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52 ? 106 3 2 2 5 3 1 2 36 6 6400 2 140 2 1 1 1 4
53 50 30 102 0.5 1 2 5 3 1 2 48 6 7300 2 135 4.1 3 3 1 4
54 20 50 87 4 2 1 4 3 1 1 216 24 3000 2 137 3.8 2 4 1 1
55 50 30 257 24 1 1 3 2 1 1 48 24 29000 2 138 3.6 2 4 3 2
56 78 18 88 2 1 2 5 3 1 2 36 6 4500 2 128 4.1 1 1 1 4
57 50 26 189 3 1 1 1 3 1 1 48 6 6500 2 139 3.4 2 4 1 1
58 90 40 220 24 1 1 3 2 4 1 24 6 14000 2 140 3.9 1 1 3 1
59 30 40 188 48 2 1 3 2 4 1 58 12 21000 2 136 3.5 2 4 3 1
60 30 56 190 4 2 1 4 3 1 2 72 24 5000 2 137 3.8 2 4 1 1
61 70 20 76 2 1 2 5 3 1 2 32 6 3300 2 123 3.9 1 1 2 4
62 30 40 99 2 2 2 5 3 4 2 46 6 6600 2 133 3.5 1 1 1 4
63 ? 44 1 2 2 5 3 4 2 72 6 7300 2 140 2.1 1 1 1 4
64 30 44 232 3 1 1 1 3 1 2 40 24 24000 2 137 4.3 2 4 1 1
65 30 40 111 4 1 1 4 3 1 1 48 24 19000 2 133 3.6 2 4 1 1
66 56 28 94 4 1 1 2 3 3 1 96 6 8300 2 143 3.6 3 3 2 1
67 60 40 98 1 1 2 5 3 1 1 60 6 7200 2 134 3.1 5 4 1 4
68 60 40 231 1 2 2 5 3 1 1 68 6 8200 2 138 4.1 5 4 1 4
69 60 36 188 3 1 1 1 3 1 2 96 12 21000 2 136 3.5 2 4 1 1
70 70 58 192 3 1 1 2 3 2 1 64 6 6300 2 139 3.6 3 3 1 1
71 54 20 190 5 1 1 4 3 1 1 168 12 21000 2 138 3.5 2 4 2 2
72 50 28 312 2 2 2 5 3 1 2 36 24 4400 2 137 3.5 2 4 1 4
73 40 30 178 4 2 1 1 3 1 2 40 24 23000 2 137 3.1 2 4 1 1
74 50 20 200 3 2 1 4 3 1 1 80 24 20000 2 142 3.6 2 4 1 1
75 30 40 220 2 2 1 4 2 1 1 216 24 20000 2 143 3.8 2 4 2 2
76 40 40 180 100 2 1 1 2 4 1 192 24 24500 2 138 3.6 2 4 2 2
77 40 30 102 100 2 1 3 2 1 1 312 24 21800 2 139 3.5 2 4 2 2
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78 60 40 100 94 2 1 3 2 1 1 214 24 18000 2 137 3.6 2 4 2 3
79 44 34 192 90 2 1 3 2 1 1 96 6 19200 2 144 3.1 2 4 1 1
80 60 20 95 2 1 2 5 3 4 2 36 6 3200 2 122 3.7 1 1 1 4
81 40 26 106 72 1 1 3 3 4 1 120 6 17000 2 142 3.2 2 4 2 2
82 86 42 88 2 1 1 3 3 1 1 96 12 17300 2 145 3.8 1 1 1 1
83 60 30 78 3 1 1 1 3 4 1 36 6 7300 2 138 3.6 3 3 1 1
84 50 26 178 3 1 1 1 3 4 1 24 24 23200 2 137 3.5 2 4 1 1
85 50 24 182 84 2 1 3 2 4 1 98 12 17800 2 122 5.5 2 4 3 2
86 50 20 177 11 1 1 3 2 1 1 24 24 23200 2 136 3.6 2 4 2 2
87 36 30 284 3 2 1 1 3 4 2 48 24 26000 2 138 3.5 2 4 1 1
88 40 40 75 70 1 1 2 3 2 1 97 12 17600 2 142 3.6 3 3 3 2
89 60 40 43 3 1 1 1 3 4 2 32 6 21000 2 144 3.7 2 4 1 1
90 50 30 183 4 2 1 1 3 1 2 40 24 24000 2 143 3.5 2 4 1 1
91 ? 199 1.5 2 2 5 3 1 2 35 12 6300 2 142 3 1 1 1 4
92 60 30 178 1 2 2 5 3 1 2 72 24 23000 2 135 3.5 2 4 1 4
93 40 40 191 4 2 1 4 3 1 1 90 12 26300 2 126 3.4 2 4 1 1
94 40 36 184 2 1 1 2 3 2 1 16 6 7300 2 136 3.6 3 3 2 1
95 60 20 84 2 1 2 5 3 1 2 32 6 3800 2 127 3.5 1 1 1 4
96 60 40 103 2 1 1 2 3 2 1 24 6 12000 2 139 3.5 3 3 1 1
97 50 30 97 20 1 1 3 2 4 1 38 1 21000 2 138 3.6 3 3 3 1
98 50 30 182 3 1 1 1 3 1 2 48 2 18300 2 137 4.2 2 4 1 1
99 40 44 104 1 2 2 5 3 1 1 52 1 7300 2 138 3.5 5 4 1 4
100 40 40 178 4 2 1 4 3 4 1 70 3 26300 2 142 3.8 2 4 1 1
